var title_f21_16_21760="Drugs palliative care child";
var content_f21_16_21760=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pediatric palliative care: Medications used to treat common symptoms in children*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Oral dose and frequency",
"       </td>",
"       <td class=\"subtitle1\">",
"        Intravenous dose and frequency",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other routes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         Dyspnea",
"        </strong>",
"       </td>",
"       <td>",
"        Morphine",
"       </td>",
"       <td>",
"        0.1 mg/kg every three to four hours as needed",
"       </td>",
"       <td>",
"        0.05 mg/kg every three to four hours as needed",
"       </td>",
"       <td>",
"        0.1 mg/kg sublingual (concentrated oral solution) every three to four hours as needed; 0.05 mg/kg subcutaneous every three to four hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lorazepam",
"       </td>",
"       <td>",
"        0.025 to 0.05 mg/kg every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.025 to 0.05 mg/kg every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.025 to 0.05 mg/kg subcutaneous every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Respiratory secretions (\"death rattle\")",
"        </strong>",
"       </td>",
"       <td>",
"        Glycopyrrolate",
"       </td>",
"       <td>",
"        0.04 to 0.1 mg/kg every four to eight hours (maximum initial dose 1 to 2 mg)",
"       </td>",
"       <td>",
"        4 mcg/kg every 4 hours as needed (maximum initial dose 0.1 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Hyoscyamine",
"       </td>",
"       <td>",
"        Age &lt;2 years: 0.03 mg/dose every four hours as needed",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Age &lt;2 years: 0.03 mg/dose sublingual every four hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age 2 to 12 years: 0.06 to 0.125 mg/dose every four hours as needed",
"       </td>",
"       <td>",
"        Age 2 to 12 years: 0.06 to 0.125 mg/dose sublingual every four hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &gt;12 years: 0.125 to 0.25 mg/dose every four hours as needed",
"       </td>",
"       <td>",
"        Age &gt;12 years: 0.125 to 0.25 mg/dose sublingual every 6 hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Scopolamine hydrobromide",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        Adolescents: 0.4 mg/dose every 8 hours as needed",
"       </td>",
"       <td rowspan=\"2\">",
"        6 mcg/kg every 8 hours as needed (maximum initial dose 0.3 mg)",
"       </td>",
"       <td>",
"        6 mcg/kg subcutaneous every 8 hours as needed (maximum initial dose 0.3 mg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adolescents: 1.5 mg transdermal patch behind ear every 72 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Fatigue",
"        </strong>",
"       </td>",
"       <td>",
"        Methylphenidate (immediate release)",
"       </td>",
"       <td>",
"        Age &ge;6 years: 0.05 to 0.1 mg/kg per dose given in the morning and at noon (maximum 2.5 mg per dose initially)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Anorexia/weight loss",
"        </strong>",
"       </td>",
"       <td rowspan=\"3\">",
"        Megestrol acetate",
"       </td>",
"       <td>",
"        Use only in children &gt;10 years old",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial dose: 3.75 mg/kg twice a day (maximum initial dose 100 mg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If no effect in 2 weeks: increase to 5 mg/kg twice a day (maximum 200 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dexamethasone",
"       </td>",
"       <td>",
"        0.15 mg/kg per dose twice a day (maximum initial dose 8 mg)",
"       </td>",
"       <td>",
"        0.15 mg/kg per dose twice a day (maximum initial dose 8 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dronabinol",
"       </td>",
"       <td>",
"        Age &ge;6 years: 2.5 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per dose every six hours",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyproheptadine",
"       </td>",
"       <td>",
"        Age &ge;8 years: 2 mg every eight hours",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"14\">",
"        <strong>",
"         Constipation",
"        </strong>",
"       </td>",
"       <td rowspan=\"2\">",
"        Polyethylene glycol 3350",
"       </td>",
"       <td>",
"        0.7 gram/kg (up to 8.5 grams initially) once daily",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase to 1.5 gram/kg (maximum 17 grams) once daily as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Senna (Syrup [8.8 mg sennosides per 5 mL strength syrup] or tablet [8.6 mg sennosides])",
"       </td>",
"       <td>",
"        6 months to 2 years: 2.2 mg (1.25 mL) to 4.4 mg (2.5 mL) at bedtime",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 to 6 years: 4.4 mg (2.5 mL) to 6.6 mg (3.75 mL) at bedtime, or 1/2 tablet at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6 to 12 years: 8.8 mg (5 mL) to 13.2 mg (7.5 mL) at bedtime, or 1 tablet at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lactulose (10 gram per 15 mL strength solution)",
"       </td>",
"       <td>",
"        7.5 mL once daily as needed or 5 to 10 mL every two hours until bowel movement (maximum 60 mL per 24 hours)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Bisacodyl",
"       </td>",
"       <td rowspan=\"2\">",
"        3 to 12 years: 0.3 mg/kg/24 hours (10 mg maximum) once daily as needed (onset 6 hours)",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        6 months to 2 years: 5 mg per rectum once daily as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 to 11 years: 5 to 10 mg per rectum once daily as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Glycerin",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        6 months to 6 years: 2 to 5 mL rectal solution or one infant suppository per rectum once daily as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;6 years: 5 to 15 mL rectal solution or one adult suppository per rectum once daily as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Docusate",
"       </td>",
"       <td>",
"        6 months to 3 years: 10 mg once to twice daily",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 to 6 years: 20 mg once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6 to 12 years: 40 mg once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mineral oil enema (Fleet)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2 to 11 years: 30 to 60 mL per rectum once daily as needed",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"13\">",
"        <strong>",
"         Nausea/vomiting",
"        </strong>",
"       </td>",
"       <td>",
"        Metoclopramide",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.1 to 0.2 mg/kg per dose three times daily before meals as needed (maximum initial dose 10 mg)",
"       </td>",
"       <td>",
"        0.1 to 0.2 mg/kg per dose three times daily before meals as needed (maximum initial dose 10 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prochlorperazine",
"       </td>",
"       <td>",
"        &gt;10 years: 0.1 mg/kg per dose every 8 hours as needed (maximum initial dose 5)",
"       </td>",
"       <td>",
"        &gt;10 years: 0.1 to 0.15 mg/kg per dose every 8 hours as needed (maximum initial dose 5)",
"       </td>",
"       <td>",
"        &gt;10 years: 0.1 mg/kg per dose as a suppository per rectum every 8 hours as needed (maximum initial dose 5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Promethazine",
"       </td>",
"       <td>",
"        &ge;2 years: 0.25 to 0.5 mg/kg per dose every four to six hours as needed (maximum initial dose 12.5 mg)",
"       </td>",
"       <td>",
"        Not recommended due to risk of tissue injury depending on IV line placement and condition",
"       </td>",
"       <td>",
"        &ge;2 years: 0.25 to 0.5 mg/kg per dose as a suppository per rectum every four to six hours as needed (maximum initial dose 12.5 mg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Ondansetron",
"       </td>",
"       <td>",
"        &lt;0.3 m",
"        <sup>",
"         2",
"        </sup>",
"        : 1 mg every eight hours as needed",
"       </td>",
"       <td rowspan=\"5\">",
"        0.15 mg/kg every eight hours as needed (maximum initial dose 8 mg)",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0.3 to 0.6 m",
"        <sup>",
"         2",
"        </sup>",
"        : 2 mg every eight hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0.6 to 1 m",
"        <sup>",
"         2",
"        </sup>",
"        : 3 mg every eight hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;1 m",
"        <sup>",
"         2",
"        </sup>",
"        : 4 to 8 mg every eight hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;11 years: 8 mg every eight hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Haloperidol",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        0.01 mg/kg per dose three times daily as needed (maximum initial dose 0.5 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diphenhydramine",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        1 mg/kg per dose every six hours as needed",
"       </td>",
"       <td>",
"        1 mg/kg per dose every six hours as needed",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lorazepam",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        0.025 to 0.05 mg/kg every six hours as need (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.02 to 0.05 mg/kg every six hours as need (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.02 to 0.05 mg/kg sublingual every six hours as need (maximum initial dose 2 mg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Dexamethasone",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        0.1 mg/kg three times a day (maximum initial dose 5 mg)",
"       </td>",
"       <td>",
"        0.1 mg/kg three times a day (maximum initial dose 5 mg)",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Dosing to prevent nausea/vomiting due to emetogenic chemotherapy or radiotherapy:",
"        </p>",
"        <p>",
"         Initial dose 10 mg/m",
"         <sup>",
"          2",
"         </sup>",
"         (maximum initial dose 20 mg); then 5 mg/m",
"         <sup>",
"          2",
"         </sup>",
"         (maximum initial dose 5 mg) every 6 hours",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Fever",
"        </strong>",
"       </td>",
"       <td>",
"        Acetaminophen",
"       </td>",
"       <td>",
"        15 mg/kg per dose every four to six hours as needed",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        15 mg/kg per rectum every four to six hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ibuprofen",
"       </td>",
"       <td>",
"        10 mg/kg every six to eight hours as needed",
"       </td>",
"       <td>",
"        Adolescent &ge;17 years: 100 to 200 mg every four to six hours as needed",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Insomnia",
"        </strong>",
"       </td>",
"       <td>",
"        Melatonin",
"       </td>",
"       <td>",
"        2 to 3 mg at bedtime",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trazodone",
"       </td>",
"       <td>",
"        &ge;6 years: 0.75 to 1 mg/kg at bedtime (12.5 to 50 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Anxiety",
"        </strong>",
"       </td>",
"       <td>",
"        Lorazepam",
"       </td>",
"       <td>",
"        0.025 to 0.05 mg/kg every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.02 to 0.05 mg/kg every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"       <td>",
"        0.02 to 0.05 mg/kg sublingual every six hours as needed (maximum initial dose 2 mg)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Agitation/delirium",
"        </strong>",
"       </td>",
"       <td rowspan=\"2\">",
"        Haloperidol",
"       </td>",
"       <td>",
"        0.01 mg/kg three times a day as needed (maximum initial dose 0.5 mg)",
"       </td>",
"       <td>",
"        0.01 mg/kg three times a day as needed (maximum initial dose 0.5 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        For acute agitation: 0.02 to 0.05 mg/kg, may repeat with a dose of 0.025 mg/kg in one hour as needed",
"       </td>",
"       <td>",
"        For acute agitation: 0.02 to 0.05 mg/kg, may repeat with a dose of 0.025 mg/kg in one hour as needed",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clonazepam",
"       </td>",
"       <td>",
"        0.005 to 0.01 mg/kg every 8 to 12 hours (maximum initial dose 0.5 mg)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Olanzapine",
"       </td>",
"       <td>",
"        Adolescents: 2.5 to 5 mg once daily",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Muscle spasm",
"        </strong>",
"       </td>",
"       <td>",
"        Diazepam",
"       </td>",
"       <td>",
"        0.04 to 0.2 mg/kg per dose every six to eight hours as needed (up to 2.5 mg per dose initially)",
"       </td>",
"       <td>",
"        0.04 to 0.2 mg/kg per dose every six to eight hours as needed (up to 2.5 mg per dose initially)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baclofen",
"       </td>",
"       <td>",
"        &ge;2 years: 5 mg three times a day, may increase every three days by 5 to 15 mg/day to a maximum dose of 40 mg/day",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"8\">",
"        <strong>",
"         Seizures",
"        </strong>",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        Lorazepam",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.05 to 0.1 mg/kg per dose; may repeat in 10 to 15 minutes (maximum cumulative dose 10 mg over twenty minutes)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Midazolam",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        Second line (refractory seizures): 0.15 mg/kg loading dose followed by continuous infusion of 1 mcg/kg/minute gradually titrated to effect",
"       </td>",
"       <td>",
"        0.2 mg/kg intranasal may repeat in 10 minutes",
"        <sup>",
"         ������",
"        </sup>",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0.3 mg/kg buccal may repeat in 10 minutes",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Diazepam",
"       </td>",
"       <td rowspan=\"5\">",
"        Adjunct for prevention of seizures: 0.04 to 0.2 mg/kg per dose every six hours (up to 2.5 mg per dose initially)",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Rectal gel formulation (Diastat&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2 to 5 years: 0.5 mg/kg per rectum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        6 to 11 years: 0.3 mg/kg per rectum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &gt;12 years: 0.2 mg/kg per rectum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doses should be rounded to 2.5, 5, 7.5, 10, 12.5, 15, 17.5 or 20 mg/dose. Dose may be repeated in 4 to 12 hours if needed",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"8\">",
"        <strong>",
"         Neuropathic pain",
"        </strong>",
"       </td>",
"       <td rowspan=\"5\">",
"        Gabapentin**",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &ge;3 years of age:",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 1 to 3: 5 mg/kg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 4 to 6: 5 mg/kg twice a day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 7 to 9: 5 mg/kg/dose three times a day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 10 to 12: 5 mg/kg/dose in the morning and midday, and 10 mg/kg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Nortriptyline",
"        <sup>",
"         &bull;&bull;",
"        </sup>",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &ge;6 years of age:",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 1 to 4: 0.2 mg/kg at bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Day 4 to 8: 0.4 mg/kg at bedtime",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Doses are for individuals over 6 months of age (except where shown otherwise) with a maximum weight of 50 kg.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Dosing shown is for scopolamine hydrobromide (oral, parenteral). Scopolamine butylbromide, widely available outside US, is not equivalent to and is dosed differently than dosing shown.",
"      <br>",
"       &Delta; Dosing shown is for nausea-vomiting related to gastrointestinal dysmotility. Higher doses (in conjunction with diphenhydramine to prevent extrapyramidal symptoms) used for chemotherapy-induced emesis.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Most data for antiemetic use of this agent is as adjunct for prevention of nausea-vomiting due to emetogenic chemotherapy or radiotherapy.",
"        <br>",
"         &sect; Also appropriate for management of opioid induced pruritis or insomnia.",
"         <br>",
"          &yen; See related topics: Treatment of seizures and epileptic syndromes in children and Management of status epilepticus in children.",
"          <br>",
"           ������ Use based on limited experience and case descriptions as adjunct. See Treatment of seizures and epileptic syndromes in children, section on transmucosal administration.",
"           <br>",
"            ������ Rectal diazepam gel has been repeated as frequently as every 15 minutes up to three doses total (in absence of IV access) to control prolonged seizure activity based on limited experience in palliative care.",
"            <br>",
"             ** Gabapentin dosing is increased until effective analgesia is achieved, side effects occur, or a maximum daily dose of 60 mg/kg/day is reached. Once a daily dose is established, half of the total daily dose may be given in the evening. Dose increases may be made more frequently (eg, every 1 to 3 days) as tolerated.",
"             <br>",
"              <span class=\"double_bullet\">",
"               &bull;&bull;",
"              </span>",
"              Nortriptyline dosing is increased as tolerated until effective analgesia is achieved, or a maximum daily dose of 1 mg/kg per day (50 mg maximum) is reached. Prior to dose escalation beyond these parameters, plasma levels and obtaining an ECG should be considered.",
"             </br>",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Custer JW, Rau RE, Lee C. The Harriet Lane Handbook, 18th ed, Elsevier Mosby, Philadelphia 2009.",
"       </li>",
"       <li>",
"        Lexicomp Online. Copyright &copy; 1978-2013 Lexicomp, Inc. All Rights Reserved.",
"       </li>",
"       <li>",
"        Schechter NL, Berde CB, Yaster M, eds. Pain in infants, children, and adolescents, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21760=[""].join("\n");
var outline_f21_16_21760=null;
var title_f21_16_21761="Substernal goiter CT II";
var content_f21_16_21761=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Substernal goiter: Appearance on CT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan showing substernal goiter in the anterior mediastinum at the level of the aortic arch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas S Ross, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21761=[""].join("\n");
var outline_f21_16_21761=null;
var title_f21_16_21762="Patient information: Superficial phlebitis (The Basics)";
var content_f21_16_21762=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/3/1075\">",
"         Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/34/30242\">",
"         Patient information: Doppler ultrasound (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/42/21155\">",
"         Patient information: Swelling (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/47/41714\">",
"         Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/17/35091\">",
"         Patient information: Chronic venous disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/44/12998\">",
"         Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Superficial phlebitis (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H633261182\">",
"      <span class=\"h1\">",
"       What is superficial phlebitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Superficial phlebitis is the medical term for when veins that are close to the surface of the skin (called the superficial veins) form clots or get inflamed. Superficial phlebitis is related to but different from another vein problem called &ldquo;deep vein thrombosis&rdquo; or &ldquo;DVT.&rdquo;",
"     </p>",
"     <p>",
"      DVT is when a vein located",
"      <strong>",
"       deep",
"      </strong>",
"      between the muscles forms a clot or gets inflamed. DVT can be very dangerous because clots within a deep vein can break off and travel to the lungs, causing something called a &ldquo;pulmonary embolism.&rdquo;",
"     </p>",
"     <p>",
"      Again, superficial phlebitis affects veins near the surface of the skin. DVT affects veins deep in the muscle.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261197\">",
"      <span class=\"h1\">",
"       Is superficial phlebitis dangerous?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Superficial phlebitis is not usually dangerous, but it can be caused by or lead to DVT, which is dangerous. Clots in a deep vein can cause a superficial phlebitis and clots in a superficial vein can extend into a deep vein and cause blood clot in the lungs. For these reasons, superficial phlebitis is taken very seriously, especially when it affects the thigh or upper arm, where superficial and deep veins meet.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261224\">",
"      <span class=\"h1\">",
"       How does superficial phlebitis relate to other vein problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People who get superficial phlebitis often also have a type of vein disease called &ldquo;venous insufficiency.&rdquo; Venous insufficiency can occur with or without varicose veins (twisted, swollen veins), and most often affects the legs.",
"     </p>",
"     <p>",
"      Here&rsquo;s an explanation of venous insufficiency: When the veins are healthy and working normally, they carry blood in only 1 direction, from the body back to the heart. Veins have valves inside them to keep blood moving toward the heart. The valves open to let blood flow to the heart, and close to keep blood from flowing backwards. When the valves are damaged or do not work well, blood flows backward and collects in the veins. This is called venous insufficiency.",
"     </p>",
"     <p>",
"      People without venous insufficiency can also get superficial phlebitis, usually after having a tube (called a catheter) or other device placed into a vein. But even people who had nothing put into a vein can get superficial phlebitis. For instance, it can happen to people with blood clotting problems or cancer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261264\">",
"      <span class=\"h1\">",
"       What are the symptoms of superficial phlebitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain, tenderness, or redness along the length of a vein",
"       </li>",
"       <li>",
"        Hardening of the vein",
"       </li>",
"       <li>",
"        Swelling of the affected arm or leg",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261279\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, if you have symptoms of superficial phlebitis see your doctor or nurse. See him or her",
"      <strong>",
"       right away",
"      </strong>",
"      if the affected arm or leg is swollen, or if the affected vein is in the thigh or upper arm.",
"     </p>",
"     <p>",
"      Call 9-1-1 for an ambulance if you get symptoms of a blood clot in the lungs, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Panting or trouble breathing",
"       </li>",
"       <li>",
"        Sharp, knife-like chest pain when you breathe in",
"       </li>",
"       <li>",
"        Coughing or coughing up blood",
"       </li>",
"       <li>",
"        A rapid heartbeat",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261294\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. Your doctor or nurse might be able to tell what is happening by doing an exam and learning about your symptoms. He or she might also do a test called an ultrasound. An ultrasound can check how well the valves in the veins work. It can also show if any of the veins are blocked, especially the deep veins.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261309\">",
"      <span class=\"h1\">",
"       How is superficial phlebitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment for superficial phlebitis focuses on easing the symptoms. To do this, doctors recommend that you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Use heating or cooling pads on the affected area",
"       </li>",
"       <li>",
"        Raise the arm or leg, propping it up on pillows or a chair when resting",
"       </li>",
"       <li>",
"        Take a medicine called an NSAID &ndash; Examples include",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil, Motrin) and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sample brand names: Aleve, Naprosyn).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your superficial phlebitis is in your leg, your doctor or nurse might also suggest you wear compression stockings. These are special socks that fit tightly over the ankle and leg. If your doctor or nurse recommends them, he or she will tell you which type to wear and how to put them on.",
"     </p>",
"     <p>",
"      Many people do not need treatment beyond that described above. In some cases, though, doctors do prescribe medicines to prevent or dissolve clots.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261324\">",
"      <span class=\"h1\">",
"       Can superficial phlebitis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting superficial phlebitis in the leg veins by staying active and not sitting too long without moving.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H633261339\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/47/41714?source=see_link\">",
"       Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1075?source=see_link\">",
"       Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30242?source=see_link\">",
"       Patient information: Doppler ultrasound (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21155?source=see_link\">",
"       Patient information: Swelling (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/17/35091?source=see_link\">",
"       Patient information: Chronic venous disease (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"       Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/16/21762?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87580 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C80C007BE0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21762=[""].join("\n");
var outline_f21_16_21762=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261182\">",
"      What is superficial phlebitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261197\">",
"      Is superficial phlebitis dangerous?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261224\">",
"      How does superficial phlebitis relate to other vein problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261264\">",
"      What are the symptoms of superficial phlebitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261279\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261294\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261309\">",
"      How is superficial phlebitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261324\">",
"      Can superficial phlebitis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633261339\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/17/35091?source=related_link\">",
"      Patient information: Chronic venous disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=related_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1075?source=related_link\">",
"      Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30242?source=related_link\">",
"      Patient information: Doppler ultrasound (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21155?source=related_link\">",
"      Patient information: Swelling (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/47/41714?source=related_link\">",
"      Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_16_21763="Intussusception Ultrasound";
var content_f21_16_21763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intussusception",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 423px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasonography shows a typical appearance of \"coiled spring\" pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nancy Fitzgerald, MD and Taylor Chung, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21763=[""].join("\n");
var outline_f21_16_21763=null;
var title_f21_16_21764="Cipro crystalluria shapes";
var content_f21_16_21764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrographs showing urine sediment of a patient with ciprofloxacin crystalluria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 526px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Needles, B) sheaves, C) stars, and D) bizarre shape. Crystals in A, C, and D are visualized under phase contrast microscopy, while those in B are seen with bright field microscopy. The crystals are shown with polarizing microscopy on the inset panels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fogazzi, GB, Garigali, G, Brambilla, C, Daudon, M. Ciprofloxacin crystalluria. Nephrol Dial Transplant 2006; 21:2982. Copyright &copy;2006 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21764=[""].join("\n");
var outline_f21_16_21764=null;
var title_f21_16_21765="PCFCL scalp";
var content_f21_16_21765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary cutaneous follicle center lymphoma with confluent skin tumors on the scalp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21765=[""].join("\n");
var outline_f21_16_21765=null;
var title_f21_16_21766="L-carnitine: Drug information";
var content_f21_16_21766=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   L-carnitine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?28/10/28836?source=see_link\">",
"    see \"L-carnitine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"    see \"L-carnitine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Carnitine-300 [OTC];",
"     </li>",
"     <li>",
"      Carnitor&reg;;",
"     </li>",
"     <li>",
"      Carnitor&reg; SF;",
"     </li>",
"     <li>",
"      L-Carnitine [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Carnitor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F187947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Dietary Supplement",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F187919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Carnitine deficiency:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral solution: Initial: 1000 mg daily in divided doses (spaced every 3-4 hours throughout the day); titrate slowly as needed to 1000-3000 mg daily in divided doses; higher doses may be needed in some patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Tablet: 990 mg 2-3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 50 mg/kg; titrate based on patient response (maximum reported dose: 300 mg/kg daily). In patients with severe metabolic crisis, a 50 mg/kg loading dose followed by an equivalent dose given over the next 24 hours (divided every 3 or 4 hours, never less than every 6 hours) may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      ESRD patients on hemodialysis:",
"     </i>",
"     I.V.:  20 mg/kg after each dialysis session; evaluate clinical response at 3-month intervals and titrate to the lowest effective dose.  Therapy should be discontinued if no improvement is seen after 9-12 months of therapy.",
"     <b>",
"      Note:",
"     </b>",
"     Current guidelines do not support the routine use of levocarnitine in dialysis patients (K/DOQI guidelines, 2000); however, the National Kidney Foundation indicates levocarnitine therapy in patients with hyporesponsiveness to erythropoietin-based products, symptomatic intradialytic hypotension, NYHA functional class III-IV or ACC/AHA stage C-D heart failure or symptomatic cardiomyopathy, or muscle weakness and fatigability affecting quality of life which are unresponsive to standard medical therapy (Eknoyan, 2003).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Valproic acid toxicity, acute (unlabeled use):",
"     </b>",
"     I.V.:  Initial: 100 mg/kg as an I.V. bolus followed by 50 mg/kg as an I.V. bolus or intermittent infusion (over 15-30 minutes) every 8 hours (maximum: 3000 mg per dose); continue until ammonia levels are decreasing and clinical improvement is evident; patients may require several days of therapy (Perrott, 2010).  Some experts recommend a maximum daily dose of 6000 mg daily and more frequent dosing (eg, every 4-6 hours) in symptomatic patients (Howland, 2011; Russell, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F187936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"      see \"L-carnitine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Carnitine deficiency:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Infants and Children: Initial: 50 mg/kg daily in divided doses; titrate slowly as needed to 50-100 mg/kg daily in divided doses (maximum: 3000 mg daily)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Valproic acid toxicity (unlabeled use):",
"     </b>",
"     I.V.:  Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F187920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16265530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Oral: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied). However, safety and efficacy of oral carnitine have not been established in ESRD. Chronic administration of high oral doses to patients with severely compromised renal function or ESRD patients on dialysis may result in accumulation of potentially toxic metabolites.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     I.V.:  No dosage adjustment provided in manufacturer&rsquo;s labeling; dosage adjustments should be determined by levocarnitine levels and clinical response.",
"     <b>",
"      Note:",
"     </b>",
"     Current guidelines do not support the routine use of levocarnitine in dialysis patients (K/DOQI guidelines, 2000); however, the National Kidney Foundation indicates levocarnitine therapy in patients with hyporesponsiveness to erythropoietin-based products, symptomatic intradialytic hypotension, NYHA functional class III-IV or ACC/AHA stage C-D heart failure or symptomatic cardiomyopathy, or muscle weakness and fatigability affecting quality of life which are unresponsive to standard medical therapy (Eknoyan, 2003).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16265531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral, I.V.: No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitine-300: 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     L-Carnitine: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 200 mg/mL (5 mL, 12.5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitor&reg;: 200 mg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: 100 mg/mL (118 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitor&reg;: 100 mg/mL (118 mL) [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitor&reg; SF: 100 mg/mL (118 mL) [sugar free; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 330 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitor&reg;: 330 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     L-Carnitine: 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F187899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Solution may be dissolved in either drink or liquid food, and should be consumed slowly; doses should be spaced every 3-4 hours throughout the day, preferably during or following meals, to improve tolerance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carnitine deficiency: Administer as a bolus dose over 2-3 minutes or by infusion. Doses should be administered every 3-6 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodialysis patients: Injection should be administered over 2-3 minutes into the venous return line after each dialysis session.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F14725395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Compatible with NS and LR at concentrations of 0.5-8 mg/mL.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F187898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Primary systemic carnitine deficiency; acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency; prevention and treatment of carnitine deficiency in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14725392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of elevated ammonia levels, coma, and/or hepatic dysfunction due to valproic acid overdose/toxicity (Eyer, 2005; Mock, 2012; Perrott, 2010; Russell, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       LevOCARNitine may be confused with levETIRAcetam, levocabastine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F187945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Intravenous:",
"     </b>",
"     Frequencies noted with hemodialysis patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (18% to 21%), chest pain (6% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (3% to 37%), dizziness (10% to 18%), fever (5% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypercalcemia (6% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (9% to 35%), vomiting (9% to 21%), abdominal pain (5% to 21%), nausea (5% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (3% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (8% to 12%), paresthesia (3% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough (9% to 18%), rhinitis (6% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Infection (10% to 24%), accidental injury (&le;12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Tachycardia (5% to 9%), palpitation (3% to 8%), peripheral edema (3% to 6%), atrial fibrillation (2% to 6%), ECG abnormality (2% to 6%), vascular disorder (2% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Depression (5% to 6%), vertigo (2% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (3% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Parathyroid disorder (2% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Taste perversion (2% to 9%), weight loss (3% to 8%), anorexia (3% to 6%), gastrointestinal disorder (2% to 6%), melena (2% to 6%), weight gain (2% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Hemorrhage (2% to 9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Amblyopia (3% to 6%), eye disorder (3% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis (3% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction (2% to 6%), drug dependence (&le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Seizures",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Gastritis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Body odor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Seizures",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Body odor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Myasthenic syndrome (uremic patients)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14725394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F187885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Carnitine deficiency: Risk factors include: Age (infants and young children are deficient in the enzyme that activates carnitine), chronic valproic acid administration, concomitant neurologic disorders, congenital metabolic disorders, hepatic cirrhosis, renal failure, critical care patients (burns, sepsis, trauma, organ failure), use of multiple antiepileptic drugs and other drugs (chemotherapy agents, antinucleoside analogues) (Katiyar, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Safety and efficacy of oral carnitine have not been established in ESRD. Chronic administration of high oral doses to patients with severely compromised renal function or ESRD patients on dialysis may result in accumulation of potentially toxic metabolites.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with seizure disorders or in those at risk of seizures (CNS mass or medications which may lower seizure threshold; both new-onset seizure activity as well as an increased frequency of seizures has been observed.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F187904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. There are no adequate and well-controlled studies in pregnant women. However, carnitine is a naturally occurring substance in mammalian metabolism.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F187925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F187905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In breast-feeding women, use must be weighed against the potential exposure of the infant to increased carnitine intake.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F187903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (LevOCARNitine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $0.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Carnitor Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/mL (5 mL): $38.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Carnitor Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g/10 mL (118 mL): $34.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Carnitor SF Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g/10 mL (118 mL): $34.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LevOCARNitine Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/mL (5 mL): $25.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LevOCARNitine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g/10 mL (118 mL): $29.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Carnitor Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     330 mg (90): $86.96",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (L-Carnitine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (90): $31.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (LevOCARNitine Fumarate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (60): $14.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (LevOCARNitine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     330 mg (90): $77.45",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F187894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     Carnitine concentrations should be obtained prior to beginning parenteral therapy, and should be monitored weekly to monthly. In metabolic disorders: monitor blood chemistry, vital signs, and plasma carnitine levels (maintain between 35-60 &mu;mol/L). In ESRD patients on dialysis: National Kidney Foundation guidelines recommend basing treatment on clinical signs and symptoms; evaluate response at 3-month intervals and discontinue if no clinical improvement noted within 9-12 months.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic acid toxicity: Evaluate valproic acid concentrations (every 4-6 hours until a downward trend is observed), electrolytes, blood gases, mental status, hepatic function, serum ammonia concentration, serum lactate, and platelets.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F187897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Normal carnitine levels are 40-50 micromole/L; levels should be maintained on therapy between 35-60 micromole/L",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F187906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Abedine (JP);",
"     </li>",
"     <li>",
"      Albicar (AR);",
"     </li>",
"     <li>",
"      Bio-Carnitine (BE);",
"     </li>",
"     <li>",
"      Biocarn (CH, DE);",
"     </li>",
"     <li>",
"      Branigen (IT);",
"     </li>",
"     <li>",
"      Cardimax (PH);",
"     </li>",
"     <li>",
"      Cardispan (CR, DO, GT, HN, MX, NI, PA, SV);",
"     </li>",
"     <li>",
"      Carnicor (ES, PH);",
"     </li>",
"     <li>",
"      Carnil (GR);",
"     </li>",
"     <li>",
"      Carnin (KP);",
"     </li>",
"     <li>",
"      Carnitene (CH, HK, NL, TW);",
"     </li>",
"     <li>",
"      Carnitina (AR, ES);",
"     </li>",
"     <li>",
"      Carnitor (GB, HK);",
"     </li>",
"     <li>",
"      Carnivit (PL);",
"     </li>",
"     <li>",
"      Carry FA (KP);",
"     </li>",
"     <li>",
"      Cartan (CL);",
"     </li>",
"     <li>",
"      Cartine (PH);",
"     </li>",
"     <li>",
"      Chudex (PL);",
"     </li>",
"     <li>",
"      Disocor (PT);",
"     </li>",
"     <li>",
"      Elcarnitol (CH);",
"     </li>",
"     <li>",
"      Entomin (JP);",
"     </li>",
"     <li>",
"      Fitmax L-Karnityna (PL);",
"     </li>",
"     <li>",
"      Hardbody L-Karnityna (PL);",
"     </li>",
"     <li>",
"      L-Cadul (KP);",
"     </li>",
"     <li>",
"      L-Carn (KP);",
"     </li>",
"     <li>",
"      L-Carnitin (AT, CZ, PL);",
"     </li>",
"     <li>",
"      L-Karnityna (PL);",
"     </li>",
"     <li>",
"      Levocarnil (FR);",
"     </li>",
"     <li>",
"      Monocamin (JP);",
"     </li>",
"     <li>",
"      Nefrocarnit (EE);",
"     </li>",
"     <li>",
"      Neurex (AR);",
"     </li>",
"     <li>",
"      Neuroactil (AR);",
"     </li>",
"     <li>",
"      Secabiol (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F187884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Carnitine is a naturally occurring metabolic compound which functions as a carrier molecule for long-chain fatty acids within the mitochondria, facilitating energy production. Carnitine deficiency is associated with accumulation of excess acyl CoA esters and disruption of intermediary metabolism. Carnitine supplementation increases carnitine plasma concentrations. The effects on specific metabolic alterations have not been evaluated. ESRD patients on maintenance hemodialysis may have low plasma carnitine levels because of reduced intake of meat and dairy products, reduced renal synthesis, and dialytic losses. Certain clinical conditions (malaise, muscle weakness, cardiomyopathy and arrhythmias) in hemodialysis patients may be related to carnitine deficiency.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In patients with valproic acid toxicity, administration of exogenous carnitine shifts the metabolism of valproic acid towards &beta;-oxidation and away from &omega;-oxidation and potentially hepatotoxic metabolite production.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F187901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (limited with moderate renal impairment), to trimethylamine (TMA) and trimethylamine N-oxide (TMAO)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: ~10% to 20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 17.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Oral: 3.3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (76%, 4% to 8% as unchanged drug); feces (&lt;1%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Eknoyan G, Latos DL, and Lindberg J, &ldquo;Practice Recommendations for the Use of L-Carnitine in Dialysis-Related Carnitine Disorder. National Kidney Foundation Carnitine Consensus Conference,&rdquo;",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 2003, 41(4):868-76",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/12666074/pubmed\" id=\"12666074\" target=\"_blank\">",
"        12666074",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eyer F, Felgenhauer N, Gempel K, et al, \"Acute Valproate Poisoning: Pharmacokinetics, Alteration in Fatty Acid Metabolism, and Changes During Therapy,\"",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 2005, 25(4):376-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/16012283/pubmed\" id=\"16012283\" target=\"_blank\">",
"        16012283",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Katiyar A and Aaron C, \"Case Files of the Children's Hospital of Michigan Regional Poison Control Center: The Use of Carnitine for the Management of Acute Valproic Acid Toxicity,\"",
"      <i>",
"       J Med Toxicol",
"      </i>",
"      , 2007, 3(3):129-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/18072149/pubmed\" id=\"18072149\" target=\"_blank\">",
"        18072149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mock CM and Schwetschenau KH, \"Levocarnitine for Valproic Acid-Induced Hyperammonemic Encephalopathy,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2012, 69(1):35-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/22180549/pubmed\" id=\"22180549\" target=\"_blank\">",
"        22180549",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Kidney Foundation, &ldquo;Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. K/DOQI,&rdquo;",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 2000, 35(6 Suppl 2):1-140.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/10895784/pubmed\" id=\"10895784\" target=\"_blank\">",
"        10895784",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perrott J, Murphy NG, and Zed PJ, \"L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2010, 44(7-8):1287-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/20587742/pubmed\" id=\"20587742\" target=\"_blank\">",
"        20587742",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Russell S, \"Carnitine as an Antidote for Acute Valproate Toxicity in Children,\"",
"      <i>",
"       Curr Opin Pediatr",
"      </i>",
"      , 2007, 19(2):206-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/17496767/pubmed\" id=\"17496767\" target=\"_blank\">",
"        17496767",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schreiber B, &ldquo;Levocarnitine and Dialysis: A Review,&rdquo;",
"      <i>",
"       Nutr Clin Pract",
"      </i>",
"      , 2005, 20(2):218-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/16/21766/abstract-text/16207659/pubmed\" id=\"16207659\" target=\"_blank\">",
"        16207659",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10109 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-217.16.9.173-E29AE5AA73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21766=[""].join("\n");
var outline_f21_16_21766=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187916\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187917\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187947\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187919\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187936\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187920\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16265530\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16265531\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187896\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187881\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187899\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14725395\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187898\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14725392\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187954\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187945\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14725394\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187885\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299590\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221274\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187892\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187904\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187925\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187905\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187903\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187894\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187897\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187906\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187884\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187901\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10109\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10109|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/10/28836?source=related_link\">",
"      L-carnitine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=related_link\">",
"      L-carnitine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_16_21767="Macrocytosis";
var content_f21_16_21767=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Macrocytosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21767/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21767/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21767/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21767/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21767/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21767/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/16/21767/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a complete blood count is obtained, there is now the virtually uniform use of an automated cell count that, by several different methods, measures a parameter that reflects the red blood cell (RBC) volume. This measurement is reported as MCV (mean corpuscular volume) in units of femtoliters (10",
"    <sup>",
"     -15",
"    </sup>",
"    liters) per RBC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link\">",
"     \"Mean corpuscular volume\"",
"    </a>",
"    .) With automated methods, a MCV above 100 femtoliters (fL) is flagged as a high value and is called macrocytosis. Examination of the peripheral smear will confirm the diagnosis, as macrocytic cells are larger than the size of the nucleus of a small lymphocyte (",
"    <a class=\"graphic graphic_picture graphicRef74901 \" href=\"UTD.htm?9/45/9942\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This topic review will discuss the differential diagnosis of an elevated MCV. Such patients may not be anemic but, if they are, the presence of macrocytosis can help to direct the subsequent evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY AND ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;RBCs enter the circulation from the bone marrow as reticulocytes, which are macrocytic. All other macrocytic RBCs are formed as a consequence of congenital or acquired abnormalities in nucleic acid metabolism of erythroid precursors, changes in membrane structure, alterations in pathways governing cell water content, or other factors (",
"    <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Conditions causing the production of macrocytic RBCs are broadly grouped into those associated with megaloblastic (eg, folate or cobalamin deficiency) or normoblastic (eg, alcoholism, liver disease, and certain drugs) RBC precursors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Reticulocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;During normal erythropoiesis, when the orthochromic normoblast extrudes its nucleus, the remaining reticulocyte has a volume of 120 to 150 fL. This cell remains in the marrow for approximately three days and then is released into the peripheral blood where it undergoes remodeling with loss of cell water and membrane. Reticulocytes in the peripheral blood have a MCV of 103 to 126 fL, a mean corpuscular hemoglobin concentration (MCHC) of 23.5 to 28.7",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    and a mean cell hemoglobin of 25.9 to 30.6 (",
"    <a class=\"graphic graphic_picture graphicRef74294 \" href=\"UTD.htm?35/61/36822\">",
"     picture 2",
"    </a>",
"    ). These values should be contrasted to normal RBC values:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      MCV &nbsp; &nbsp;= &nbsp; 83 &nbsp;to 97 fL",
"     </li>",
"     <li>",
"      MCHC &nbsp;= &nbsp; 31 to 34",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"     </li>",
"     <li>",
"      MCH &nbsp; &nbsp;= &nbsp; 28 to 32",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lower reticulocyte values for MCHC and MCH reflect their increase in cell water [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus, any circumstance that produces a reticulocytosis may be accompanied by a macrocytosis (defined as a MCV above 100 fL). Two other mechanisms can contribute to macrocytosis in this setting:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One of the actions of erythropoietin (EPO), which is secreted in response to anemia, is to cause skipped cell divisions in an attempt to hasten the delivery of RBCs into the peripheral blood (",
"      <a class=\"graphic graphic_figure graphicRef61552 \" href=\"UTD.htm?32/34/33325\">",
"       figure 1",
"      </a>",
"      ). Since there are fewer divisions, ie, the cytoplasm is divided amongst fewer RBCs, the resulting RBCs will be macrocytic.",
"     </li>",
"     <li>",
"      Under circumstances of marrow \"stress,\" erythropoiesis can be forced to regress to \"fetal programs\" characterized by a switching on of fetal hemoglobin (Hb F) and expression of fetal blood group antigens. The net result is the production of \"stress\" or \"shunt\" reticulocytes, which are larger and which live longer periods of time in the circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Alcoholism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol is a common cause of macrocytosis. Even before anemia appears, approximately 90 percent of alcoholics have a macrocytosis (MCV between 100 and 110 fL) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. This abnormality can be induced by the regular ingestion of 80 grams of alcohol each day (eg, one bottle of wine) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alcohol-induced macrocytosis occurs even though patients are folate and cobalamin replete and do not have liver disease. Abstinence from alcohol results in resolution of the macrocytosis within two to four months. Return of the MCV to normal also confirms the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4710?source=see_link&amp;anchor=H5#H5\">",
"     \"Alcohol abuse and hematologic disorders\", section on 'Macrocytosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism whereby alcohol ingestion causes macrocytosis is unknown, although it has been demonstrated that acetaldehyde, a metabolic breakdown product of alcohol, is capable of inducing membrane changes in red cell precursors and circulating red cells of alcoholics with macrocytosis, through the in vivo production of aldehyde adducts [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/8\">",
"     8",
"    </a>",
"    ]. Acetaldehyde also interferes with cellular division in vitro, resulting in an increase in the volume of cells in culture [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, one study has shown a significant correlation between the MCV in heavy drinkers (&gt;300 grams of alcohol per week) and the genotype of aldehyde dehydrogenase, the enzyme largely responsible for determining blood levels of acetaldehyde following ethanol ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver disease, particularly if caused by alcohol, is another common cause of macrocytosis, which is often accompanied by target cell formation (",
"    <a class=\"graphic graphic_picture graphicRef80318 \" href=\"UTD.htm?4/3/4151\">",
"     picture 3",
"    </a>",
"    ). The mechanism is not known but increased lipid deposition on red cell membranes may be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Interference with DNA synthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrocytosis can occur as the result of interference with DNA synthesis. This may be the result of folate or cobalamin deficiency (eg, inadequate dietary intake or malabsorption), or following treatment with drugs that either inhibit absorption of cobalamin or folate from the gastrointestinal tract, or inhibit various enzymes required for DNA synthesis (",
"    <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef55010 \" href=\"UTD.htm?26/43/27323\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77437 \" href=\"UTD.htm?30/51/31547\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Folate and cobalamin deficiency are associated with megaloblastic erythroid hyperplasia (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 4",
"    </a>",
"    ); the presence of macroovalocytes is a clue to underlying megaloblastic erythropoiesis (",
"    <a class=\"graphic graphic_picture graphicRef74901 \" href=\"UTD.htm?9/45/9942\">",
"     picture 1",
"    </a>",
"    ). The ultimate basis for production of the megaloblast is inadequate conversion of deoxyuridate to thymidylate, which leads to slowing of DNA synthesis and delayed nuclear maturation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link&amp;anchor=H7#H7\">",
"     \"Physiology of vitamin B12 and folate deficiency\", section on 'Pathophysiology of megaloblastosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the causes of drug-induced macrocytosis are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    (inhibition of ribonucleotide reductase),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (inhibition of dihydrofolate reductase),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (or 6-mercaptopurine),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/11\">",
"     11",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"     cladribine",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"     table 1",
"    </a>",
"    ). In some hospital laboratories, zidovudine has become the most common cause of macrocytosis (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Evaluation'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of some of these agents (especially",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    ) is uniformly associated with macrocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], and macrocytosis has often been used to monitor the patient's adherence to regimens including these agents [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=see_link&amp;anchor=H17#H17\">",
"     \"Hematologic manifestations of HIV infection: Anemia\", section on 'Bone marrow suppression'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32202?source=see_link&amp;anchor=H10#H10\">",
"     \"Prognosis and treatment of essential thrombocythemia\", section on 'Hydroxyurea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, there may be a genetic predisposition to develop macrocytosis and bone marrow toxicity with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    . Approximately 0.3 percent of normal subjects have very low levels of thiopurine methyltransferase, one of the enzymes responsible for azathioprine metabolism. This abnormality is genetically determined and is associated with a significant risk of myelosuppression and a macrocytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=see_link\">",
"     \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Myelodysplastic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually all patients with the myelodysplastic syndrome will have macrocytic anemia at presentation, along with varying degrees of neutropenia, monocytosis, circulating blast forms, reticulocytopenia, and thrombocytopenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Pathologic features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Myelodysplastic syndromes, in their early stages, may be a common cause of apparently idiopathic macrocytic anemia, particularly in elderly patients. In one report of nine elderly patients, none of whom fulfilled the FAB criteria for myelodysplastic syndrome, eight had molecular and cytogenetic changes compatible with hematologic dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasional patients with hypothyroidism",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    myxedema display macrocytosis without marrow megaloblastosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/2\">",
"     2",
"    </a>",
"    ]. The mechanism is unclear. There is a 10 percent incidence of pernicious anemia in patients with hypothyroidism due to chronic autoimmune thyroiditis, which is associated with antiparietal cell antibodies, megaloblastic changes in the bone marrow, and impaired absorption of cobalamin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations of hypothyroidism\", section on 'Gastrointestinal disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Imatinib and sunitinib",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrocytosis has been noted following the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/1/17434?source=see_link\">",
"     imatinib",
"    </a>",
"    in patients with chronic myeloid leukemia or gastrointestinal stromal tumors as well as in patients with renal cell carcinoma treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Both agents are orally active tyrosine kinase inhibitors capable of inhibiting c-kit. The mechanism is unknown, although interference with the c-kit pathway in a mouse model leads to macrocytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory error",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain artifacts may occur to normal-sized RBC as a result of the use of automated cell counters. How this occurs and how it can be detected are discussed below (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Spurious macrocytosis'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     INFANTS AND CHILDREN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal values for the MCV in infants and children differ from adult values [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=see_link&amp;anchor=H7#H7\">",
"     \"Approach to the child with anemia\", section on 'Mean corpuscular volume'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The MCV of red cells in the cord blood of term infants is 106 &plusmn; 4 fL, while the MCV in those born at &le;25 weeks of gestation is 119 &plusmn; 7 fL.",
"     </li>",
"     <li>",
"      After birth, the median MCV in healthy children falls to 77 fL by six months of age and slowly rises to adult values by about the age of 18 years.",
"     </li>",
"     <li>",
"      A working definition of macrocytosis in the age range of six months to 12 years of age is &gt;90 fL, a value which exceeds the 97th percentile of normal for this age range.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The etiology of macrocytosis also differs somewhat between adults and children. Alcoholism is rare in children but use of drugs such as anticonvulsants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    , drugs that interfere with DNA synthesis such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    , and immunosuppressive agents often leads to macrocytosis. Congenital heart disease, Down syndrome, and other rare genetic syndromes (eg, Fanconi anemia, congenital dyserythropoietic anemia, thiamine-responsive megaloblastic anemia syndrome) are also associated with macrocytosis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. As in adults, reticulocytosis, myelodysplasia, bone marrow failure, disorders of folate or B12 metabolism, and liver disease are commonly associated with macrocytosis in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The report of an MCV above 100 fL in an adult usually requires some action. A report from a family practice group found macrocytosis in 2 to 4 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/28\">",
"     28",
"    </a>",
"    ], while a study of 1784 randomly selected elderly subjects living at home found macrocytosis in 6.3 percent of men and 3.3 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/29\">",
"     29",
"    </a>",
"    ]. The most common causes were alcoholism, liver disease, hypothyroidism, and the megaloblastic anemias. The evaluation of such patients should begin with a focused history including the extent of alcohol abuse, exposure to antimetabolites and other medications, nutritional status (especially in the elderly and alcoholics), and the possible presence of liver disease.",
"   </p>",
"   <p>",
"    However, many laboratories have observed that macrocytosis increasingly has become associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    (AZT) treatment of patients with HIV infection. As an example, in a study of 100 consecutive inpatients in a large urban metropolitan hospital who had an MCV &gt;110 fL, 44 percent were treated with AZT, 19 percent were alcoholics, 12 percent had malignant neoplasms, 4 percent had vitamin B12 deficiency, and 3 percent had",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/12\">",
"     12",
"    </a>",
"    ]. Other anti-retroviral agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    ) have also been associated with macrocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unless the history clearly points to a diagnosis, routine laboratory testing consists of examination of the blood smear, reticulocyte count, and analysis of serum for cobalamin, folate, thyroid stimulating hormone (TSH), tests of liver function, and protein electrophoresis for the rare case of multiple myeloma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Initial diagnostic strategy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Blood smear and reticulocyte count",
"    </span>",
"    &nbsp;&mdash;&nbsp;The red cell indices and complete blood count generally establish the presence of macrocytosis. The next step is measurement of the reticulocyte count and examination of the blood smear. The appearance of the macrocytes can be helpful. As examples, the presence of macro-ovalocytes suggests cobalamin or folate deficiency, while the presence of macrocytic target cells suggests liver disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reticulocytosis can be excluded as a cause if the absolute reticulocyte count (red blood cell count &nbsp;x &nbsp;percent reticulocytes &nbsp;&divide; &nbsp;100) is less than",
"      <span class=\"nowrap\">",
"       100,000/microL.",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H38#H38\">",
"       \"Approach to the adult patient with anemia\", section on 'Reticulocyte count'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Megaloblastic anemia is suggested by an MCV above 110 fL, macroovalocytosis, and hypersegmented neutrophils on blood smear (&gt;5 percent of neutrophils having five lobes or the presence of &gt;1 percent of neutrophils with six lobes or more) (",
"      <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"       picture 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Myelodysplasia is suggested by the presence of varying degrees of cytopenia involving one or more cell lines, along with evidence for lineage dysplasia on the blood smear (eg, macrocytic RBCs, hypolobulated or hypogranular neutrophils, large",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abnormally granulated platelets, monocytosis, and occasional blast forms) in patients with normal values for B12 and folate. In such patients, a complete blood count with formal differential count and platelet count should be obtained along with bone marrow aspiration and biopsy with cytogenetic analysis in order to establish the diagnosis of MDS",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      to rule out aplastic anemia or leukemia. As noted above, many elderly patients with apparently idiopathic macrocytosis have molecular and cytogenetic changes compatible with hematologic dysplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link\">",
"       \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Spurious macrocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spurious macrocytosis refers to artifacts that can occur to normal-sized RBC as a result of the use of automated cell counters. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H20#H20\">",
"     \"Automated hematology instrumentation\", section on 'Causes of spurious results'",
"    </a>",
"    .) There are three major mechanisms by which this can occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some cases are strictly machine-related, as with the use of high concentrations of EDTA&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Osmotic swelling of RBCs within the counting apparatus can occur following an episode of hyperglycemia in diabetic patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/34\">",
"       34",
"      </a>",
"      ]. In this setting, the hypertonic red cells swell when exposed to the hypotonic solution in the counter.",
"     </li>",
"     <li>",
"      Cold or warm agglutinins in the patient, activated by temperature changes either in the sample prior to counting or to",
"      <span class=\"nowrap\">",
"       heating/cooling",
"      </span>",
"      of the RBC solution within the apparatus itself, will cause RBCs to pass through the counter in small groups, rather than one by one, and will be counted as macrocytic cells [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are two general ways to determine that these sorts of artifact have occurred. First, examination of the peripheral smear (or alternatively of a warmed or cooled RBC suspension) may confirm RBC agglutination. Second, examination of the erythrocyte volume histograms as printed out by the automated counter may show that RBC doublets and triplets are present, ie, RBCs with an MCV two to three times that of the patient's normal RBC [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/33\">",
"     33",
"    </a>",
"    ]. These should disappear on warming of the sample if cold agglutinins are present but should not change if warm autoantibodies are present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Megaloblastic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of the serum cobalamin and red blood cell or serum folate concentrations should establish the diagnosis of cobalamin or folate deficiency. However, serum folate levels may be misleading, since alcohol lowers the folate level even in patients who are not truly deficient. In addition, even one adequate meal can correct the serum folate in patients who are deficient. Once the diagnosis of cobalamin or folate deficiency is established, the patient should be evaluated to determine the cause of the deficiency. The limitations of testing for these two deficiencies are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Low serum cobalamin or folate concentrations should distinguish megaloblastic anemia from alcoholism, although the latter can be complicated by folate or cobalamin deficiency. Attempts to use complex discriminant analysis of cell counters have not substantially improved the ability to resolve the differential diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although macrocytosis may suggest the possible presence of folate or cobalamin deficiency, the absence of macrocytosis does not exclude the diagnosis since the characteristic red cell changes are not seen in all patients. In one recent series, for example, the diagnosis of cobalamin deficiency by serum testing was made in patients in whom only 29 percent had anemia and only 64 percent had a MCV greater than 100 fL [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21767/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some patients, the macrocytosis may be masked by a concurrent disorder associated with the production of small RBCs (microcytosis), such as iron deficiency, one of the thalassemic syndromes, or prolonged hypoferremia. Such patients should have both microcytes and macrocytes on examination of the peripheral smear as well as a significantly increased RDW (red cell distribution width), a measure of the dispersion of individual values for red cell size around the mean.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Definition of macrocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;With automated methods for determination of the complete blood count, a red blood cell mean corpuscular volume (MCV) &gt;100 femtoliters (fL) in adults is flagged as a high value and is called macrocytosis.",
"   </p>",
"   <p>",
"    Normal values for the MCV differ among adults, newborn, infants, and children. Thus, the definition of macrocytosis is different for these age groups. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Infants and children'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Confirmation of macrocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the peripheral smear will confirm the presence of macrocytic red cells, as they have a diameter greater than that of the nucleus of a small lymphocyte. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Blood smear and reticulocyte count'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Certain laboratory errors and medical conditions can cause \"spurious\" macrocytosis, which should be suspected when the reported MCV is elevated but macrocytes are not present on the peripheral smear. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Spurious macrocytosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of macrocytosis are discussed within the text (",
"    <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"     table 1",
"    </a>",
"    ). The most common causes of macrocytosis in adults are an elevated reticulocyte count, alcoholism, liver disease, hypothyroidism, the megaloblastic anemias, and the use of certain drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology and etiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Determining the cause",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unless the history clearly points to a diagnosis, routine laboratory testing consists of the following. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Examination of the blood smear",
"     </li>",
"     <li>",
"      Reticulocyte count",
"     </li>",
"     <li>",
"      Analysis of serum for cobalamin, folate, and thyroid stimulating hormone",
"     </li>",
"     <li>",
"      Liver function testing",
"     </li>",
"     <li>",
"      Protein electrophoresis for the rare case of multiple myeloma",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/1\">",
"      Hoffbrand V, Provan D. ABC of clinical haematology. Macrocytic anaemias. BMJ 1997; 314:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/2\">",
"      Colon-Otero G, Menke D, Hook CC. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am 1992; 76:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/3\">",
"      d'Onofrio G, Chirillo R, Zini G, et al. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/4\">",
"      Houwen B. Reticulocyte maturation. Blood Cells 1992; 18:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/5\">",
"      Sepp&auml; K, Sillanaukee P, Saarni M. Blood count and hematologic morphology in nonanemic macrocytosis: differences between alcohol abuse and pernicious anemia. Alcohol 1993; 10:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/6\">",
"      Savage D, Lindenbaum J. Anemia in alcoholics. Medicine (Baltimore) 1986; 65:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/7\">",
"      Girard DE, Kumar KL, McAfee JH. Hematologic effects of acute and chronic alcohol abuse. Hematol Oncol Clin North Am 1987; 1:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/8\">",
"      Latvala J, Parkkila S, Melkko J, Niemel&auml; O. Acetaldehyde adducts in blood and bone marrow of patients with ethanol-induced erythrocyte abnormalities. Mol Med 2001; 7:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/9\">",
"      Wickramasinghe SN, Malik F. Acetaldehyde causes a prolongation of the doubling time and an increase in the modal volume of cells in culture. Alcohol Clin Exp Res 1986; 10:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/10\">",
"      Hashimoto Y, Nakayama T, Futamura A, et al. Erythrocyte mean cell volume and genetic polymorphism of aldehyde dehydrogenase 2 in alcohol drinkers. Blood 2002; 99:3487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/11\">",
"      Karvellas CJ, Sawyer M, Hamilton M, Mackey JR. Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer. Am J Clin Oncol 2004; 27:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/12\">",
"      Snower DP, Weil SC. Changing etiology of macrocytosis. Zidovudine as a frequent causative factor. Am J Clin Pathol 1993; 99:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/13\">",
"      Burns ER, Reed LJ, Wenz B. Volumetric erythrocyte macrocytosis induced by hydroxyurea. Am J Clin Pathol 1986; 85:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/14\">",
"      Engstr&ouml;m KG, L&ouml;fvenberg E. Treatment of myeloproliferative disorders with hydroxyurea: effects on red blood cell geometry and deformability. Blood 1998; 91:3986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/15\">",
"      Steele RH, Keogh GL, Quin J, et al. Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): a surrogate marker for adherence. Int J STD AIDS 2002; 13:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/16\">",
"      Woodson LC, Dunnette JH, Weinshilboum RM. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 1982; 222:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/17\">",
"      Anttila P, Ihalainen J, Salo A, et al. Idiopathic macrocytic anaemia in the aged: molecular and cytogenetic findings. Br J Haematol 1995; 90:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/18\">",
"      Gillessen S, Graf L, Korte W, Cerny T. Macrocytosis and cobalamin deficiency in patients treated with sunitinib. N Engl J Med 2007; 356:2330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/19\">",
"      Billemont B, Izzedine H, Rixe O. Macrocytosis due to treatment with sunitinib. N Engl J Med 2007; 357:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/20\">",
"      Rini BI, Choueiri TK, Elson P, et al. Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. Cancer 2008; 113:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/21\">",
"      Schallier D, Trullemans F, Fontaine C, et al. Tyrosine kinase inhibitor-induced macrocytosis. Anticancer Res 2009; 29:5225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/22\">",
"      Rajaraman S, Davis WS, Mahakali-Zama A, et al. An allelic series of mutations in the Kit ligand gene of mice. II. Effects of ethylnitrosourea-induced Kitl point mutations on survival and peripheral blood cells of Kitl(Steel) mice. Genetics 2002; 162:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/23\">",
"      Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. J Perinatol 2008; 28:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/24\">",
"      Dallman PR, Siimes MA. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr 1979; 94:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/25\">",
"      Pappo AS, Fields BW, Buchanan GR. Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies. Pediatrics 1992; 89:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/26\">",
"      David O, Fiorucci GC, Tosi MT, et al. Hematological studies in children with Down syndrome. Pediatr Hematol Oncol 1996; 13:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/27\">",
"      Borgna-Pignatti C, Azzalli M, Pedretti S. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. J Pediatr 2009; 155:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/28\">",
"      Davenport J. Macrocytic anemia. Am Fam Physician 1996; 53:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/29\">",
"      Inelmen EM, D'Alessio M, Gatto MR, et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study. Aging (Milano) 1994; 6:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/30\">",
"      Khawcharoenporn T, Shikuma CM, Williams AE, Chow DC. Lamivudine-associated macrocytosis in HIV-infected patients. Int J STD AIDS 2007; 18:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/31\">",
"      Eyer-Silva WA, Arabe J, Pinto JF, Morais-De-S&aacute; CA. Macrocytosis in patients on stavudine. Scand J Infect Dis 2001; 33:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/32\">",
"      Harkins LS, Sirel JM, McKay PJ, et al. Discriminant analysis of macrocytic red cells. Clin Lab Haematol 1994; 16:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/33\">",
"      Hinchliffe RF, Bellamy GJ, Lilleyman JS. Use of the Technicon H1 hypochromia flag in detecting spurious macrocytosis induced by excessive K2-EDTA concentration. Clin Lab Haematol 1992; 14:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/34\">",
"      Holt JT, DeWandler MJ, Arvan DA. Spurious elevation of the electronically determined mean corpuscular volume and hematocrit caused by hyperglycemia. Am J Clin Pathol 1982; 77:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/35\">",
"      Weiss GB, Bessman JD. Spurious automated red cell values in warm autoimmune hemolytic anemia. Am J Hematol 1984; 17:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/36\">",
"      Bessman JD, Banks D. Spurious macrocytosis, a common clue to erythrocyte cold agglutinins. Am J Clin Pathol 1980; 74:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21767/abstract/37\">",
"      Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994; 69:144.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7166 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-E2FE460E4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21767=[""].join("\n");
var outline_f21_16_21767=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY AND ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Reticulocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Alcoholism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Liver disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Interference with DNA synthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Imatinib and sunitinib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory error",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      INFANTS AND CHILDREN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Blood smear and reticulocyte count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Spurious macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Megaloblastic anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Definition of macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Confirmation of macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Determining the cause",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7166\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7166|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/34/33325\" title=\"figure 1\">",
"      Reticulocyte shift",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7166|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/45/9942\" title=\"picture 1\">",
"      Macroovalocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/61/36822\" title=\"picture 2\">",
"      Reticulocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/3/4151\" title=\"picture 3\">",
"      Target cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/47/4854\" title=\"picture 4\">",
"      Megaloblastic smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7166|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/47/9980\" title=\"table 1\">",
"      Causes of macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/43/27323\" title=\"table 2\">",
"      Causes of folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/51/31547\" title=\"table 3\">",
"      Causes of B12 deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4710?source=related_link\">",
"      Alcohol abuse and hematologic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=related_link\">",
"      Approach to the child with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=related_link\">",
"      Automated hematology instrumentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=related_link\">",
"      Hematologic manifestations of HIV infection: Anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=related_link\">",
"      Mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=related_link\">",
"      Physiology of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/28/32202?source=related_link\">",
"      Prognosis and treatment of essential thrombocythemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_16_21768="Clinical features and diagnosis of meconium aspiration syndrome";
var content_f21_16_21768=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of meconium aspiration syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21768/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/16/21768/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meconium aspiration syndrome (MAS) is defined as respiratory distress in newborn infants born through meconium-stained amniotic fluid (MSAF) whose symptoms cannot be otherwise explained [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/1\">",
"     1",
"    </a>",
"    ]. MAS can present with varying degrees of severity from mild respiratory distress to life-threatening respiratory failure.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of MAS will be discussed here. The management and complications of MAS are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=see_link\">",
"     \"Prevention and management of meconium aspiration syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, a retrospective multi-center study of 162,075 term infants born between 1997 and 2007 reported 1.8 percent of infants had an admission diagnosis of meconium aspiration syndrome (MAS) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MAS occurs in about 2 to 10 percent of infants born through meconium-stained amniotic fluid (MSAF). This was illustrated in a study from a single tertiary center of 20,047 live births between 1994 and 1998 that reported MSAF occurring in 9.2 percent and MAS in 0.1 percent of all live births [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This 10-fold difference in the incidence of MAS may be due to differences between the two studies in the rigor that MAS was diagnosed and measures used to prevent MAS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=see_link&amp;anchor=H182584917#H182584917\">",
"     \"Prevention and management of meconium aspiration syndrome\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of MSAF varies with gestational age with a nadir at about 31 weeks. This was best illustrated by a large English multicenter study of about 500,000 singleton births that reported rates of MSAF in preterm, term, and postterm infants of 5.1, 16.5, and 27.1 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/4\">",
"     4",
"    </a>",
"    ]. However, in the subgroup of premature infants, rates were higher for those born &le;30 weeks compared with those with a gestational age between 31 and 36 weeks. After 31 weeks, the incidence of MSAF increases with gestational age. After excluding preterm infants, the rates of MSAF were higher in black (22.6 percent) and South Asian infants (16.8 percent) compared with those who were white (15.7 percent). Logistic regression analysis showed independent predictors for MSAF included advanced gestation, black or South Asian ethnicity, and vaginal breech delivery.",
"   </p>",
"   <p>",
"    The risk of MAS and MSAF is greatest in postmature infants and small for gestational age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/5\">",
"     5",
"    </a>",
"    ]. Changes in obstetric care, especially a reduction in postmature births, appear to be associated with a decrease in the incidence of MAS. This was illustrated in the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 1365 infants &ge;37 weeks gestational age born through MSAF at a single center from 1990 to 1998, MAS decreased nearly fourfold (5.8 to 1.5 percent in 1990 to 1992 and 1997 to 1998, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/6\">",
"       6",
"      </a>",
"      ]. This was associated with a significant reduction in births &ge;41 weeks gestation (42 to 28 percent), as well as increased use of amnioinfusion, diagnosis of nonreassuring fetal heart rate patterns, and cesarean delivery.",
"     </li>",
"     <li>",
"      A significant decrease in the incidence of severe MAS (requiring intubation and mechanical ventilation) was also noted over an eight-year period in Australia and New Zealand from 1995 to 2002 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/7\">",
"       7",
"      </a>",
"      ]. The lowest incidence was 0.35 per 1000 live births in 2002. The lower incidence was attributed to improving obstetrical management with fewer deliveries beyond 41 weeks gestation and fewer infants with five-minute Apgar scores of less than 7 (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?13/24/13697?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). These two changes accounted for approximately 62 percent of the reduction in severe MAS cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of meconium aspiration syndrome (MAS) involves intrauterine passage of meconium, aspiration, and pulmonary disease, which results in hypoxemia and acidosis (",
"    <a class=\"graphic graphic_algorithm graphicRef56521 \" href=\"UTD.htm?23/55/24445\">",
"     algorithm 1",
"    </a>",
"    ). Persistent pulmonary hypertension of the newborn (PPHN) frequently accompanies severe MAS and contributes to hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Birth depression occurs in 20 to 33 percent of infants born through meconium-stained amniotic fluid (MSAF) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/9-11\">",
"     9-11",
"    </a>",
"    ] and likely is caused by pathologic intrauterine processes, primarily chronic asphyxia and infection. This intrauterine stress leads to the passage and aspiration of meconium by the fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Composition of meconium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meconium is a thick, black-green, odorless material first demonstrable in the fetal intestine during the third month of gestation. Meconium results from the accumulation of debris, including desquamated cells from the intestine and skin, gastrointestinal mucin, lanugo hair, fatty material from the vernix caseosa, amniotic fluid, and intestinal secretions. It contains blood group-specific glycoproteins and a small amount of lipid and protein that decreases during gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The black-green color results from bile pigments.",
"   </p>",
"   <p>",
"    Meconium is sterile. However, when aspirated into the lung, it may stimulate the release of cytokines and other vasoactive substances that lead to cardiovascular and inflammatory responses in the fetus and newborn [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In patients with MAS, pulmonary function improves with the fall of proinflammatory cytokines over the first 96 hours of life [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/16\">",
"     16",
"    </a>",
"    ]. There is also animal data that implicates pancreatic phospholipase A2 as a potential source of the lung [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Meconium passage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Passage of meconium occurs early in the first trimester of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/18\">",
"     18",
"    </a>",
"    ]. Fetal defecation slows after 16 weeks gestation and becomes infrequent by 20 weeks, concurrent with innervation of the anal sphincter [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/19\">",
"     19",
"    </a>",
"    ]. From approximately 20 to 34 weeks, fetal passage of meconium remains infrequent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/20\">",
"     20",
"    </a>",
"    ]. Almost all fetuses and newborn infants who pass meconium are at term or postterm gestation.",
"   </p>",
"   <p>",
"    Meconium passage may be caused by increased peristalsis and relaxation of the anal sphincter due to increased vagal outflow associated with umbilical cord compression or increased sympathetic inflow during hypoxia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. In one study, fetuses that passed meconium prior to birth had higher motilin levels in cord blood compared to those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/24\">",
"     24",
"    </a>",
"    ]. The higher levels of motilin, a regulatory intestinal peptide, were thought to be related to increased parasympathetic tone due to fetal hypoxia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41205?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of the development of the gastrointestinal tract\", section on 'Hormonal regulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meconium in amniotic fluid can be aspirated during fetal gasping or in the initial breaths after delivery. Normally, fetal breathing activity results in movement of lung fluid out of the trachea [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/25\">",
"     25",
"    </a>",
"    ]. However, as shown in animals, prolonged hypoxia stimulates fetal breathing and gasping that can lead to inhalation of amniotic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Pathologic evidence suggests that this process also occurs in humans. Meconium has been found in the lungs of infants who were stillborn [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/30\">",
"     30",
"    </a>",
"    ] or who died soon after birth without a history of aspiration at delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Meconium that remains in the hypopharynx or trachea after delivery can be aspirated during the initial breaths. This is more likely to occur in a depressed infant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aspirated meconium can interfere with normal breathing by several mechanisms. They include airway obstruction, chemical irritation and inflammation, infection, and surfactant inactivation. However, it is likely that most cases of severe MAS are primarily caused by intrauterine pathologic processes, primarily asphyxia and infection, rather than the aspiration of meconium by itself [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Airway obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway obstruction can be complete or partial. Complete obstruction leads to distal atelectasis. Partial airway obstruction occurs when particulate meconium partly occludes the airway. Because the airway diameter is larger in inspiration, gas can enter around the partial obstruction. However, as the airway narrows during exhalation, the meconium plug occludes the airway completely, trapping the gas distally. This process is known as a ball valve effect and can lead to overdistention of the lung and alveolar rupture, with resulting pneumothorax or other air leak complications [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link\">",
"     \"Pulmonary air leak in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Chemical irritation and inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Components of meconium cause inflammation of the lung that is apparent 24 to 48 hours after inhalation. Direct injury and inflammation result in an exudative and inflammatory pneumonitis with epithelial disruption, proteinaceous exudation with alveolar collapse, and cellular necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. In animal studies, pancreatic phospholipase A2 appears to directly contribute to lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;MSAF is a risk factor for bacterial infection of the amniotic cavity and should alert the clinician to the potential for increased neonatal morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/40-42\">",
"     40-42",
"    </a>",
"    ] Although meconium is sterile, the mucopolysaccharide component provides an excellent growth medium for microorganisms, especially Escherichia coli [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/43\">",
"     43",
"    </a>",
"    ]. Meconium also may inhibit phagocytosis by polymorphonuclear cells and their oxidative burst [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21512?source=see_link\">",
"     \"Neonatal pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Surfactant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have shown the deleterious effects of meconium on surfactant metabolism.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased inactivation &ndash; Animal models of meconium aspiration demonstrate inactivation of surfactant with increased surface tension, and decreased lung volume, compliance, and oxygenation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/45-49\">",
"       45-49",
"      </a>",
"      ]. In human infants, concentrations of surfactant inhibitors (eg, total protein, albumin, membrane-derived phospholipid) were higher in lung lavage fluid in those with MAS than in controls [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/36\">",
"       36",
"      </a>",
"      ]. However, surfactant phospholipid and surfactant protein A levels were not different. In addition, several meconium components (eg, free fatty acids) have a higher minimal surface area and may displace surfactant from the alveolar surface.",
"     </li>",
"     <li>",
"      Decreased synthesis &ndash; In a small study, there was a trend toward lower surfactant synthesis in neonates with MAS or persistent pulmonary hypertension (PPHN) who required extracorporeal membrane oxygenation, compared to control infants who required ventilatory support for nonpulmonary indications [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/50\">",
"       50",
"      </a>",
"      ]. Lower tracheal aspirate concentrations of phosphatidylcholine (PC), a component of surfactant, and lower incorporation of radiolabeled carbon in PC were seen in infants with MAS or PPHN compared to controls.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hypoxemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoxemia results from several causes, including decreased alveolar ventilation related to lung injury, and ventilation-perfusion imbalance with continued perfusion of poorly ventilated lung units. PPHN frequently accompanies MAS, with right-to-left shunting caused by increased pulmonary vascular resistance, and resultant hypoxemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the pulmonary manifestations of meconium aspiration syndrome (MAS), the following features are seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of meconium-stained amniotic fluid (MSAF) or evidence of meconium staining on physical examination of the infant. The vernix, umbilical cord, and nails may be meconium-stained, depending upon how long the infant has been exposed in utero [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/51\">",
"       51",
"      </a>",
"      ]. In general, nails will become stained after six hours and vernix after 12 to 14 hours of exposure.",
"     </li>",
"     <li>",
"      Birth depression occurs in 20 to 33 percent of infants born through MSAF [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/9-11,52\">",
"       9-11,52",
"      </a>",
"      ]. These infants have neurologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory depression at birth typically due to hypoxia or shock [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/52\">",
"       52",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39975?source=see_link\">",
"       \"Etiology, clinical manifestations, and evaluation of neonatal shock\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Affected infants are frequently small for gestational age or postmature [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/5\">",
"       5",
"      </a>",
"      ]. Characteristic findings of postmaturity include peeling skin, long fingernails, and decreased vernix. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=see_link\">",
"       \"Small for gestational age infant\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/26/31142?source=see_link\">",
"       \"Postterm infant\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94133577\">",
"    <span class=\"h2\">",
"     Pulmonary findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with MAS typically have respiratory distress with marked tachypnea and cyanosis. Reduced pulmonary compliance and use of accessory muscles of respiration are evidenced by intercostal and subxiphoid retractions and abdominal (paradoxical) breathing, often with grunting and nasal flaring.",
"   </p>",
"   <p>",
"    Infants who develop MAS exhibit signs of respiratory distress immediately after birth. In a study of 394 term infants with MSAF, MAS developed in 18 patients with Apgar scores &lt;8 (19 percent) and in one patient with an Apgar score &ge;9 (0.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/53\">",
"     53",
"    </a>",
"    ]. All 19 patients had signs of respiratory distress within 15 minutes of birth, which required ventilatory support in 16 of the infants. These results demonstrate that full-term infants with MSAF without any sign of respiratory distress or depression immediately after birth are unlikely to develop MAS.",
"   </p>",
"   <p>",
"    Affected infants typically have a barrel-shaped chest with an increased anterior-posterior diameter caused by overinflation. Auscultation reveals rales and rhonchi. These signs usually are seen immediately after birth. However, some patients are asymptomatic at birth and develop worsening signs of pulmonary decompensation as the meconium moves from the large airways into the lower tracheobronchial tree.",
"   </p>",
"   <p>",
"    In patients with severe MAS, pneumothorax and pneumomediastinum are common findings. Patient with severe disease are at risk for respiratory failure, which is often associated with persistent pulmonary hypertension (PPHN). Infants with pulmonary hypertension and right-to-left shunting may have a gradient in oxygenation between preductal and postductal arterial blood samples. In addition, echocardiography may demonstrate right-to-left shunting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link&amp;anchor=H4#H4\">",
"     \"Pulmonary air leak in the newborn\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link&amp;anchor=H7#H7\">",
"     \"Persistent pulmonary hypertension of the newborn\", section on 'Maladaptation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of meconium aspiration syndrome (MAS) is made by the following clinically based findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is evidence of meconium-stained amniotic fluid (MSAF) or infant. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Respiratory distress at birth or shortly after birth. (See",
"      <a class=\"local\" href=\"#H94133577\">",
"       'Pulmonary findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Characteristic radiographic features. The initial chest film may show streaky, linear densities similar in appearance to transient tachypnea of the newborn. As the disease progresses, the lungs typically appear hyperinflated with flattening of the diaphragms [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/54-56\">",
"       54-56",
"      </a>",
"      ]. Diffuse patchy densities may alternate with areas of expansion. In infants with severe disease who require high concentrations of supplemental oxygen and mechanical ventilation, the lungs may develop an appearance of homogeneous density similar to respiratory distress syndrome. Radiographic changes resolve over the course of 7 to 10 days but sometimes persist for several weeks. Air leak occurs in 10 to 30 percent of infants with MAS [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/10,57\">",
"       10,57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/2/32804?source=see_link\">",
"       \"Transient tachypnea of the newborn\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link&amp;anchor=H4#H4\">",
"       \"Pulmonary air leak in the newborn\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If the infant requires intubation because of depression, the diagnosis is made by the presence of meconium in the trachea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=see_link&amp;anchor=H182584961#H182584961\">",
"       \"Prevention and management of meconium aspiration syndrome\", section on 'Neonatal care'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although arterial blood gas measurements typically demonstrate hypoxemia and hypercarbia, these findings are nonspecific and are not used to diagnosis MAS. However, arterial blood gas measurements and pulse oximetry are used to assess the respiratory status of the infant. (See",
"    <a class=\"local\" href=\"#H94134215\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of meconium aspiration syndrome (MAS) includes other causes of neonatal respiratory distress, which occur in 4 to 9 percent of infants born through meconium-stained amniotic fluid (MSAF) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21768/abstract/52\">",
"     52",
"    </a>",
"    ]. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transient tachypnea of the newborn (60 percent)",
"     </li>",
"     <li>",
"      Delayed transition from fetal circulation (18 percent)",
"     </li>",
"     <li>",
"      Sepsis or pneumonia (11 percent)",
"     </li>",
"     <li>",
"      Persistent pulmonary hypertension of the newborn (3 percent)",
"     </li>",
"     <li>",
"      Miscellaneous conditions, including pulmonary edema, pneumothorax, hypovolemia, blood aspiration (8 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MAS is distinguished from these based on the history, clinical course, and radiographic findings as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transient tachypnea of the newborn (TTN) is a frequent cause of respiratory distress in late preterm infants (34 to 37 weeks gestation), whereas MAS is most frequently seen in postmature infants (&gt;41 weeks gestation). In addition, patients with TTN improve quickly in contrast to those with MAS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/2/32804?source=see_link\">",
"       \"Transient tachypnea of the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with delayed transition from fetal circulation improve quickly in comparison to those with MAS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8502?source=see_link\">",
"       \"Physiologic transition from intrauterine to extrauterine life\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Respiratory distress syndrome (RDS) generally occurs in preterm infants, whereas MAS usually occurs in postmature infants. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19656?source=see_link&amp;anchor=H18#H18\">",
"       \"Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumonia may be difficult to differentiate from MAS. As a result, infants with presumed MAS are treated with antibiotics while awaiting the results of cultures. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21512?source=see_link\">",
"       \"Neonatal pneumonia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=see_link\">",
"       \"Prevention and management of meconium aspiration syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=see_link&amp;anchor=H9#H9\">",
"       \"Prevention and management of meconium aspiration syndrome\", section on 'Antibiotics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital cyanotic heart disease is differentiated from MAS by physical examination, chest radiography, and echocardiography. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link\">",
"       \"Diagnosis and initial management of cyanotic heart disease in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Isolated air leaks such as pneumothorax is differentiated from MAS by history (absence of meconium-stained amniotic fluid) and chest radiography. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link&amp;anchor=H4#H4\">",
"       \"Pulmonary air leak in the newborn\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94134215\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation for suspected meconium aspiration syndrome (MAS) includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chest radiograph is used in confirming the diagnosis of MAS (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arterial blood gas is used to assess the respiratory status of the affected neonate. It is used to determine whether mechanical ventilation is indicted in patients with severe respiratory distress. Pulse oximetry is used to continue to monitor the infant&rsquo;s oxygenation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=see_link&amp;anchor=H3#H3\">",
"       \"Mechanical ventilation in neonates\", section on 'Indications for ventilation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=see_link&amp;anchor=H15#H15\">",
"       \"Oxygen monitoring and therapy in the newborn\", section on 'Pulse oximetry'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Echocardiography may be indicated in patients with severe respiratory distress to exclude the diagnosis of structural heart disease, and to identify patients with persistent pulmonary hypertension (PPHN). In PPHN, echocardiography demonstrates normal structural anatomy with evidence of pulmonary hypertension (eg, flattened or displaced ventricular septum) and right-to-left shunting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link&amp;anchor=H12#H12\">",
"       \"Persistent pulmonary hypertension of the newborn\", section on 'Electrocardiogram'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Because it is difficult to differentiate MAS from pneumonia, blood cultures and, if possible, tracheal aspirate cultures are obtained. Empiric antibiotic therapy is started while awaiting culture results. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H170900680\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meconium aspiration syndrome (MAS) is defined as respiratory distress in an infant born through meconium-stained amniotic fluid (MSAF) whose symptoms cannot be otherwise explained. MAS can present with varying degrees of severity from mild respiratory distress to life-threatening with respiratory failure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With changes in obstetric care, the incidence of MAS has declined to about 0.1 to 1.8 percent of live births in developed countries. Risk factors for MAS include postmaturity and small for gestational age. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathophysiology of MAS involves intrauterine passage of meconium, aspiration, and pulmonary disease resulting in hypoxemia, acidosis, and potentially pulmonary hypertension (",
"      <a class=\"graphic graphic_algorithm graphicRef56521 \" href=\"UTD.htm?23/55/24445\">",
"       algorithm 1",
"      </a>",
"      ). Pulmonary disease is a result of aspirated meconium interfering with normal lung function due to airway obstruction, chemical irritation and inflammation, and deleterious effects on surfactant metabolism (ie, inactivation and reduced production). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with MAS typically have a history of MSAF or evidence of meconium staining on physical examination. They are frequently small for gestational age or postmature. Many infants with MAS also have neurologic or respiratory depression due to perinatal hypoxia. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients present with respiratory distress with marked tachypnea, cyanosis, intercostal and subxiphoid retractions, abdominal breathing, grunting, and nasal flaring. The chest appears barrel-shaped (increase anterior-posterior diameter) due to overinflation. In patients with severe MAS, complications include air leaks (eg, pneumothorax) and persistent pulmonary hypertension (PPHN). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pulmonary disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link\">",
"       \"Pulmonary air leak in the newborn\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"       \"Persistent pulmonary hypertension of the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of MAS is based on the clinical findings of MSAF or meconium-stained infant, respiratory distress, and characteristic radiographic features. The radiologic findings are initially streaky, linear densities, followed by hyperinflation, and alternating diffuse patchy densities with areas of expansion. In patients who require intubation, the diagnosis is established by the presence of meconium in the trachea. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MAS is differentiated from other causes of neonatal respiratory distress (eg, transient tachypnea of the newborn, neonatal pneumonia, and congenital cyanotic heart disease) based upon the history, physical examination, clinical course, and radiographic findings. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of suspected MAS includes chest radiography, arterial blood gas and pulse oximetry, blood cultures, and if possible, tracheal aspirate cultures. In patients with more severe disease, an echocardiography may be indicated to exclude structural heart disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      PPHN. (See",
"      <a class=\"local\" href=\"#H94134215\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/1\">",
"      Fanaroff AA. Meconium aspiration syndrome: historical aspects. J Perinatol 2008; 28 Suppl 3:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/2\">",
"      Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during a ten-year period. J Perinatol 2009; 29:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/3\">",
"      Whitfield JM, Charsha DS, Chiruvolu A. Prevention of meconium aspiration syndrome: an update and the Baylor experience. Proc (Bayl Univ Med Cent) 2009; 22:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/4\">",
"      Balchin I, Whittaker JC, Lamont RF, Steer PJ. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol 2011; 117:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/5\">",
"      Clausson B, Cnattingius S, Axelsson O. Outcomes of post-term births: the role of fetal growth restriction and malformations. Obstet Gynecol 1999; 94:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/6\">",
"      Yoder BA, Kirsch EA, Barth WH, Gordon MC. Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol 2002; 99:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/7\">",
"      Dargaville PA, Copnell B, Australian and New Zealand Neonatal Network. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 2006; 117:1712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/8\">",
"      Davis PJ, Shekerdemian LS. Meconium aspiration syndrome and extracorporeal membrane oxygenation. Arch Dis Child Fetal Neonatal Ed 2001; 84:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/9\">",
"      Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 1998; 45:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/10\">",
"      Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we made a difference? Pediatrics 1990; 85:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/11\">",
"      Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome. Unresolved issues. Pediatr Clin North Am 1993; 40:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/12\">",
"      RAPOPORT S, BUCHANAN DJ. The composition of Meconium; isolation of blood-group-specific polysaccharides; abnormal compositions of meconium in meconium ileus. Science 1950; 112:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/13\">",
"      C&ocirc;t&eacute; RH, Valet JP. Isolation, composition and reactivity of the neutral glycoproteins from human meconiums with specificities of the ABO and Lewis systems. Biochem J 1976; 153:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/14\">",
"      Sienko A, Altshuler G. Meconium-induced umbilical vascular necrosis in abortuses and fetuses: a histopathologic study for cytokines. Obstet Gynecol 1999; 94:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/15\">",
"      Hsieh TT, Hsieh CC, Hung TH, et al. Differential expression of interleukin-1 beta and interleukin-6 in human fetal serum and meconium-stained amniotic fluid. J Reprod Immunol 1998; 37:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/16\">",
"      Cayabyab RG, Kwong K, Jones C, et al. Lung inflammation and pulmonary function in infants with meconium aspiration syndrome. Pediatr Pulmonol 2007; 42:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/17\">",
"      Sippola T, Aho H, Peuravuori H, et al. Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr Res 2006; 59:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/18\">",
"      Mulivor RA, Mennuti MT, Harris H. Origin of the alkaline phosphatases in amniotic fluid. Am J Obstet Gynecol 1979; 135:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/19\">",
"      Abramovich DR, Gray ES. Physiologic fetal defecation in midpregnancy. Obstet Gynecol 1982; 60:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/20\">",
"      Matthews TG, Warshaw JB. Relevance of the gestational age distribution of meconium passage in utero. Pediatrics 1979; 64:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/21\">",
"      Miller FC. Meconium staining of the aminiotic fluid. Clin Obstet Gynaecol 1979; 6:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/22\">",
"      Yeomans ER, Gilstrap LC 3rd, Leveno KJ, Burris JS. Meconium in the amniotic fluid and fetal acid-base status. Obstet Gynecol 1989; 73:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/23\">",
"      Lucas A, Christofides ND, Adrian TE, et al. Fetal distress, meconium, and motilin. Lancet 1979; 1:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/24\">",
"      Mahmoud EL, Benirschke K, Vaucher YE, Poitras P. Motilin levels in term neonates who have passed meconium prior to birth. J Pediatr Gastroenterol Nutr 1988; 7:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/25\">",
"      Dawes GS, Fox HE, Leduc BM, et al. Respiratory movements and rapid eye movement sleep in the foetal lamb. J Physiol 1972; 220:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/26\">",
"      Block MF, Kallenberger DA, Kern JD, Nepveux RD. In utero meconium aspiration by the baboon fetus. Obstet Gynecol 1981; 57:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/27\">",
"      Hooper SB, Harding R. Changes in lung liquid dynamics induced by prolonged fetal hypoxemia. J Appl Physiol 1990; 69:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/28\">",
"      Boddy K, Dawes GS. Fetal breathing. Br Med Bull 1975; 31:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/29\">",
"      Manning FA, Martin CB Jr, Murata Y, et al. Breathing movements before death in the primate fetus (Macaca mulatta). Am J Obstet Gynecol 1979; 135:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/30\">",
"      Brown BL, Gleicher N. Intrauterine meconium aspiration. Obstet Gynecol 1981; 57:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/31\">",
"      Byrne DL, Gau G. In utero meconium aspiration: an unpreventable cause of neonatal death. Br J Obstet Gynaecol 1987; 94:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/32\">",
"      Sunoo C, Kosasa TS, Hale RW. Meconium aspiration syndrome without evidence of fetal distress in early labor before elective cesarean delivery. Obstet Gynecol 1989; 73:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/33\">",
"      Ghidini A, Spong CY. Severe meconium aspiration syndrome is not caused by aspiration of meconium. Am J Obstet Gynecol 2001; 185:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/34\">",
"      Tran N, Lowe C, Sivieri EM, Shaffer TH. Sequential effects of acute meconium obstruction on pulmonary function. Pediatr Res 1980; 14:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/35\">",
"      Tyler DC, Murphy J, Cheney FW. Mechanical and chemical damage to lung tissue caused by meconium aspiration. Pediatrics 1978; 62:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/36\">",
"      Dargaville PA, South M, McDougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/37\">",
"      Yamada T, Minakami H, Matsubara S, et al. Meconium-stained amniotic fluid exhibits chemotactic activity for polymorphonuclear leukocytes in vitro. J Reprod Immunol 2000; 46:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/38\">",
"      de Beaufort AJ, Pelikan DM, Elferink JG, Berger HM. Effect of interleukin 8 in meconium on in-vitro neutrophil chemotaxis. Lancet 1998; 352:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/39\">",
"      Yamada T, Matsubara S, Minakami H, et al. Chemotactic activity for polymorphonuclear leukocytes: meconium versus meconium-stained amniotic fluid. Am J Reprod Immunol 2000; 44:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/40\">",
"      Romero R, Hanaoka S, Mazor M, et al. Meconium-stained amniotic fluid: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1991; 164:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/41\">",
"      Rao S, Pavlova Z, Incerpi MH, Ramanathan R. Meconium-stained amniotic fluid and neonatal morbidity in near-term and term deliveries with acute histologic chorioamnionitis and/or funisitis. J Perinatol 2001; 21:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/42\">",
"      Mazor M, Furman B, Wiznitzer A, et al. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol 1995; 86:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/43\">",
"      Bryan, CS. Enhancement of bacterial infection by meconium. John Hopkins Medical Journal 1967; 121:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/44\">",
"      Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol 1995; 173:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/45\">",
"      Chen CT, Toung TJ, Rogers MC. Effect of intra-alveolar meconium on pulmonary surface tension properties. Crit Care Med 1985; 13:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/46\">",
"      Clark DA, Nieman GF, Thompson JE, et al. Surfactant displacement by meconium free fatty acids: an alternative explanation for atelectasis in meconium aspiration syndrome. J Pediatr 1987; 110:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/47\">",
"      Davey AM, Becker JD, Davis JM. Meconium aspiration syndrome: physiological and inflammatory changes in a newborn piglet model. Pediatr Pulmonol 1993; 16:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/48\">",
"      Hall SB, Notter RH, Smith RJ, Hyde RW. Altered function of pulmonary surfactant in fatty acid lung injury. J Appl Physiol 1990; 69:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/49\">",
"      al-Mateen KB, Dailey K, Grimes MM, Gutcher GR. Improved oxygenation with exogenous surfactant administration in experimental meconium aspiration syndrome. Pediatr Pulmonol 1994; 17:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/50\">",
"      Janssen DJ, Carnielli VP, Cogo P, et al. Surfactant phosphatidylcholine metabolism in neonates with meconium aspiration syndrome. J Pediatr 2006; 149:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/51\">",
"      BROWN CA, DESMOND MM, LINDLEY JE, MOORE J. Meconium staining of newborn infants. J Pediatr 1956; 49:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/52\">",
"      Wiswell TE, Gannon CM, Jacob J, et al. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics 2000; 105:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/53\">",
"      van Ierland Y, de Boer M, de Beaufort AJ. Meconium-stained amniotic fluid: discharge vigorous newborns. Arch Dis Child Fetal Neonatal Ed 2010; 95:F69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/54\">",
"      Gooding CA, Gregory GA. Roentgenographic analysis of meconium aspiration of the newborn. Radiology 1971; 100:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/55\">",
"      PETERSON HG Jr, PENDLETON ME. Contrasting roentgenographic pulmonary patterns of the hyaline membrane and fetal aspiration syndromes. Am J Roentgenol Radium Ther Nucl Med 1955; 74:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/56\">",
"      Yeh TF, Harris V, Srinivasan G, et al. Roentgenographic findings in infants with meconium aspiration syndrome. JAMA 1979; 242:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21768/abstract/57\">",
"      Wiswell TE, Henley MA. Intratracheal suctioning, systemic infection, and the meconium aspiration syndrome. Pediatrics 1992; 89:203.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4971 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-F93BED5DA7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21768=[""].join("\n");
var outline_f21_16_21768=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H170900680\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Composition of meconium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Meconium passage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Chemical irritation and inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Surfactant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H94133577\">",
"      Pulmonary findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H94134215\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H170900680\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4971\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4971|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?23/55/24445\" title=\"algorithm 1\">",
"      Pathophysiology of MAS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?13/24/13697?source=related_link\" title=\"calculator 1\">",
"      Calculator: Apgar score",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=related_link\">",
"      Diagnosis and initial management of cyanotic heart disease in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39975?source=related_link\">",
"      Etiology, clinical manifestations, and evaluation of neonatal shock",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=related_link\">",
"      Mechanical ventilation in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/0/21512?source=related_link\">",
"      Neonatal pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/15/41205?source=related_link\">",
"      Overview of the development of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=related_link\">",
"      Oxygen monitoring and therapy in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19656?source=related_link\">",
"      Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=related_link\">",
"      Persistent pulmonary hypertension of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8502?source=related_link\">",
"      Physiologic transition from intrauterine to extrauterine life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/26/31142?source=related_link\">",
"      Postterm infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18648?source=related_link\">",
"      Prevention and management of meconium aspiration syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=related_link\">",
"      Pulmonary air leak in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=related_link\">",
"      Small for gestational age infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/2/32804?source=related_link\">",
"      Transient tachypnea of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=related_link\">",
"      Treatment and outcome of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_16_21769="Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis";
var content_f21_16_21769=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Hordur S Hardarson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Gary R Fleisher, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/16/21769/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/16/21769/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral infection of the central nervous system (CNS) most often leads to meningitis, meningoencephalitis, or encephalitis, in descending order of frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/1\">",
"     1",
"    </a>",
"    ]. Encephalitis is inflammation of the brain parenchyma, manifest by neurologic dysfunction (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; seizure; hemiparesis; and paresthesias) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Encephalitis implies inflammation of the brain and strictly speaking is a pathological diagnosis. However, in practice, most patients with encephalitis are diagnosed based on clinical manifestations of brain dysfunction and laboratory or imaging evidence of inflammation (ie, white blood cells in the cerebrospinal fluid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inflammation on brain imaging).",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of viral encephalitis in children and adolescents will be discussed here. The pathogenesis, etiology, treatment, and prevention of viral encephalitis in children and adolescents and viral encephalitis in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31590?source=see_link\">",
"     \"Acute viral encephalitis in children and adolescents: Pathogenesis and etiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/18/23848?source=see_link\">",
"     \"Acute viral encephalitis in children and adolescents: Treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38968?source=see_link\">",
"     \"Viral encephalitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Encephalitis is an acute, life-threatening emergency, requiring prompt intervention. Although discussed separately, the assessment and management often are performed simultaneously (",
"    <a class=\"graphic graphic_table graphicRef51779 \" href=\"UTD.htm?19/29/19933\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Encephalitis causes neurologic dysfunction and has a broad range of presenting symptoms and signs. The clinical manifestations vary depending upon which portions of the central nervous system (CNS) are affected (although the clinical syndromes overlap to some extent), the pathogenetic agent, and various host factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic clinical features of viral infection at specific sites of the CNS are listed below. The distinction between the various entities is frequently blurred.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meningitis &ndash; Fever, headache, nausea, vomiting, photophobia, and stiff neck (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=see_link&amp;anchor=H3#H3\">",
"       \"Viral meningitis: Clinical features and diagnosis in children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Encephalitis &ndash; Fever, headache, nausea, vomiting, or altered level of consciousness, often with seizure and focal neurologic signs",
"     </li>",
"     <li>",
"      Rhombencephalitis (brain stem encephalitis) &ndash; Myoclonic jerks, tremor, ataxia, cranial nerve involvement, respiratory distress, shock, and coma",
"     </li>",
"     <li>",
"      Myelitis &ndash; Muscle weakness, bladder dysfunction, flaccid paralysis, and reduced or absent reflexes (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H8#H8\">",
"       \"Disorders affecting the spinal cord\", section on 'Acute viral myelitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Radiculitis &ndash; Muscle weakness, shooting pain, dysesthesia, and diminished reflexes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Neonates and young infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other infections in neonates (0 to 28 days) and young infants, the presentation of encephalitis can be nonspecific. Encephalitis should be considered in a neonate or young infant who has fever, seizure, poor feeding, irritability, lethargy, or decreased perfusion. Fever is a variable finding. In a series of 63 neonates with herpes simplex virus (HSV) CNS disease, 49 percent had lethargy, 57 percent had seizure, 63 percent had skin vesicles, and 44 percent had fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonates who have viral illness, especially HSV and enterovirus, are at risk for severe CNS and systemic illness. Clinicians should have a low threshold for considering encephalitis in the ill-appearing neonate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Infections in neonates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H4#H4\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;In older children and adolescents, encephalitis can present with fever, psychiatric symptoms, emotional lability, movement disorder, ataxia, seizures, stupor, lethargy, coma, or localized neurologic changes (eg, hemiparesis, cranial nerve defect, ataxia) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective series of 50 children (6 weeks to 18 years of age) with encephalitis, the following manifestations were present at the time of admission [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Encephalopathy, defined as depressed or altered level of consciousness (including lethargy, extreme irritability, significant change in personality or behavior) persisting for &ge;24 hours (100 percent)",
"     </li>",
"     <li>",
"      Fever (80 percent)",
"     </li>",
"     <li>",
"      Seizure (78 percent; 79 percent of these were focal)",
"     </li>",
"     <li>",
"      Focal neurologic signs other then seizure (56 percent)",
"     </li>",
"     <li>",
"      Decreased consciousness (47 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of acute viral encephalitis may include status epilepticus, cerebral edema, inappropriate secretion of antidiuretic hormone, cardiorespiratory failure, and disseminated intravascular coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     VIRAL ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses and autoimmune disorders are the most frequently diagnosed causes of encephalitis, although no etiology is discovered in the majority of cases, despite intensive testing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/7\">",
"     7",
"    </a>",
"    ]. A wide variety of viruses can cause encephalitis (",
"    <a class=\"graphic graphic_table graphicRef62512 \" href=\"UTD.htm?12/2/12334\">",
"     table 2",
"    </a>",
"    ). Among those most commonly isolated are enteroviruses, herpes simplex virus (HSV) types 1 and 2, other",
"    <em>",
"     Herpesviridae",
"    </em>",
"    , and arboviruses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31590?source=see_link&amp;anchor=H9#H9\">",
"     \"Acute viral encephalitis in children and adolescents: Pathogenesis and etiology\", section on 'Viral pathogens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous mimics of viral encephalitis (",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    ). These conditions generally require specific therapy, and prompt initiation of therapy may improve outcome. Information from the history, examination, laboratory, and radiologic evaluation is used to distinguish between viral encephalitis and other conditions in the differential diagnosis. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Approach to diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial, parasitic, fungal, and rickettsial infections of the central nervous system (CNS) can mimic viral encephalitis (",
"    <a class=\"graphic graphic_table graphicRef62512 \" href=\"UTD.htm?12/2/12334\">",
"     table 2",
"    </a>",
"    ). These infections usually are diagnosed through culture, serology, nucleic acid amplification tests (eg, polymerase chain reaction [PCR]), examination of blood smears, and other microbiologic methods [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Laboratory evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial meningitis &ndash; The clinical manifestations and cerebrospinal fluid (CSF) indices of bacterial meningitis and viral encephalitis may overlap (",
"      <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"       table 4",
"      </a>",
"      ). In such cases, the diagnosis of bacterial meningitis is confirmed by identification of a bacterial pathogen from the CSF (by culture or other diagnostic techniques) or isolation of bacteria from the blood in a patient with CSF pleocytosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H29#H29\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CNS tuberculosis &ndash;",
"      <em>",
"       Mycobacterium tuberculosis",
"      </em>",
"      can present with encephalitis and can have CSF findings similar to those in patients with viral encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/7\">",
"       7",
"      </a>",
"      ]. An extremely low glucose (&lt;10",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      and elevated protein (&gt;200",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      are characteristic of tuberculous meningitis and occur rarely with viral encephalitis. Tuberculin skin testing is indicated but can be nonreactive in up to 40 percent of cases; chest radiographs are normal in one-half of cases. When tuberculosis is diagnosed in children, it is important to identify the source of the infection through contact investigation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=see_link\">",
"       \"Central nervous system tuberculosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link\">",
"       \"Tuberculosis disease in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Free-living amebae &ndash; Primary amebic meningoencephalitis caused by",
"      <em>",
"       Naegleria fowleri",
"      </em>",
"      and granulomatous amebic meningoencephalitis caused by",
"      <em>",
"       Acanthamoeba",
"      </em>",
"      spp. or",
"      <em>",
"       Balamuthia mandrillaris",
"      </em>",
"      are CNS infections caused by free-living amebae. These infections are rare and almost always fatal. Of six cases reported in the United States in 2007, all had exposure to recreational freshwater from July to September, and all died [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/9\">",
"       9",
"      </a>",
"      ].",
"      <em>",
"       Balamuthia mandrillaris",
"      </em>",
"      encephalitis was diagnosed in 10 patients (five children) among 3500 cases referred to the California Encephalitis Project (1999 to 2008); all but one patient were of Hispanic ethnicity, five had a history of contact with soil, nine patients died, and one was lost to follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/10\">",
"       10",
"      </a>",
"      ]. Diagnosis was made by polymerase chain reaction (PCR) for",
"      <em>",
"       Balamuthia",
"      </em>",
"      mitochondrial 16S rRNA gene DNA on brain tissue, other tissue,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CSF. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4762?source=see_link\">",
"       \"Free-living amebas\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Postinfectious",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postinfectious encephalitis (ie, acute disseminated encephalomyelitis, ADEM), is a monophasic illness that is thought to be an autoimmune response to a preceding antigenic challenge (eg, a febrile illness or immunization) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. Associated preceding illnesses may include measles, mumps, rubella, varicella zoster, Epstein-Barr virus, cytomegalovirus, herpes simplex virus, hepatitis A virus, influenza, and enterovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Associated immunizations may include anthrax, influenza, Japanese encephalitis virus, measles, rabies, smallpox, and yellow fever.",
"   </p>",
"   <p>",
"    The onset of postinfectious encephalitis is usually subacute and fever is typically absent at the time of neurologic manifestations. However, it can be difficult to distinguish postinfectious from acute encephalitis clinically. Characteristic magnetic resonance imaging findings of postinfectious encephalitis include multifocal white-matter lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=see_link\">",
"     \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14169267\">",
"    <span class=\"h2\">",
"     Autoimmune encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-N-methyl-D-aspartate receptor (NMDAR) and voltage-gated potassium channel antibodies (VGKC Ab) are being increasingly recognized as causes of encephalitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/56/906?source=see_link&amp;anchor=H3370782#H3370782\">",
"     \"Paraneoplastic and autoimmune encephalitis\", section on 'Antibodies to synaptic proteins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a multi-center, population-based, prospective study of encephalitis, antibody studies were performed in 46 patients in whom an infectious cause was not identified; 16 cases of autoimmune mediated disease were identified (seven had antibodies to VGKC complexes and nine to NMDAR) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/15\">",
"     15",
"    </a>",
"    ]. Anti-NMDAR encephalitis was the most frequently identified etiology among patients &le;30 years of age who were referred to the California Encephalitis Project with encephalitis between 2007 and 2011 (32 of 79 patients in whom an etiology was identified) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/14\">",
"     14",
"    </a>",
"    ]. Approximately two-thirds of cases occurred in children &le;18 years.",
"   </p>",
"   <p>",
"    Anti-NMDAR encephalitis should be considered in children and adolescents who present with psychiatric symptoms, abnormal movements, seizure, autonomic instability, and hypoventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. It is important to identify anti-NMDAR encephalitis because it may be associated with tumors (eg, ovarian teratomas) and often responds to specific therapeutic interventions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/56/906?source=see_link&amp;anchor=H3370789#H3370789\">",
"     \"Paraneoplastic and autoimmune encephalitis\", section on 'Anti-NMDA receptor encephalitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Toxic-metabolic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Encephalitis must be differentiated from encephalopathy caused by metabolic disorders, drugs, and toxins (",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"     table 5",
"    </a>",
"    ). These disorders can usually be distinguished from viral encephalitis by the lack of acute febrile illness, more gradual onset, lack of CSF pleocytosis, absence of focal changes on brain imaging, and presence in some cases of abnormal laboratory findings (eg, electrolyte abnormalities, hypoglycemia, acidosis, hyperammonemia, elevated blood lead level, positive toxicology screen). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Intracranial pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain abscess and other noninfectious intracranial pathology, such as tumor, intracranial bleed, or thrombosis usually can be differentiated from encephalitis through neuroimaging. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     APPROACH TO DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of encephalitis requires a rapid, comprehensive, and systematic approach. Early identification of the underlying cause can be crucial for patient management and prognosis. Although discussed separately, the assessment and management often are performed jointly in practice (",
"    <a class=\"graphic graphic_table graphicRef51779 \" href=\"UTD.htm?19/29/19933\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The evaluation of the child with altered brain function begins with assessment of the airway, breathing, and circulation. The first priorities are stabilization of cardiorespiratory status and management of seizures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=see_link\">",
"     \"Initial assessment and stabilization of children with respiratory or circulatory compromise\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link&amp;anchor=H34#H34\">",
"     \"Management of status epilepticus in children\", section on 'Initial pharmacologic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the child is stabilized, a thorough history, physical examination, initial laboratory tests, lumbar puncture, and neuroimaging are performed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. Electroencephalography (EEG) should be performed as soon as is feasible. In cases with a clinically suspected focal lesion of the central nervous system (CNS), neuroimaging should be performed before lumbar puncture if time allows. Epidemiologic, historical (",
"    <a class=\"graphic graphic_table graphicRef57122 \" href=\"UTD.htm?22/25/22941\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73833 \" href=\"UTD.htm?21/49/22300\">",
"     table 7",
"    </a>",
"    ), and examination clues (",
"    <a class=\"graphic graphic_table graphicRef71744 \" href=\"UTD.htm?21/8/21645\">",
"     table 8",
"    </a>",
"    ) and data from the initial laboratory and imaging tests may help to narrow the differential diagnosis (",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    ) and direct additional evaluation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    therapy. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A systematic approach is necessary for prompt recognition and appropriate management. The goals of the evaluation are to define the clinical syndrome (eg, acute encephalitis, postinfectious encephalitis, autoimmune encephalitis, meningitis, toxic or metabolic encephalopathy, etc) and to identify a specific etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. Some of the causes of encephalitis and encephalopathy require specific therapy (",
"    <a class=\"graphic graphic_table graphicRef62512 \" href=\"UTD.htm?12/2/12334\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    ), and prompt initiation of therapy may improve outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, identification of a specific etiology may be useful for prognosis, potential prophylaxis, and public health interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31590?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute viral encephalitis in children and adolescents: Pathogenesis and etiology\", section on 'Terminology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is often necessary to obtain the history from caregivers, relatives, or friends because of the patient's altered level of consciousness or young age. It is important to ask specific questions regarding travel and exposures (eg, animals, insects, toxins, etc), particularly within the two to three weeks before onset (although exposure to rabies can be remote), immunizations, and immune status when evaluating a patient with suspected encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/2,8\">",
"     2,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epidemiologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    historical clues to particular viral pathogens are provided in the tables (",
"    <a class=\"graphic graphic_table graphicRef57122 \" href=\"UTD.htm?22/25/22941\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73833 \" href=\"UTD.htm?21/49/22300\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include careful neurologic evaluation for focal findings. Neurologic evaluation should include assessment of the mental status and motor, sensory, cranial nerve, cerebellar, and reflex function. The Glasgow coma scale score (GCS) (",
"    <a class=\"graphic graphic_table graphicRef59662 \" href=\"UTD.htm?2/58/2989\">",
"     table 9",
"    </a>",
"    ), although not validated in patients with nontraumatic brain injury, may be helpful in quantifying the level of consciousness and monitoring neurologic progression.",
"   </p>",
"   <p>",
"    Examination findings may suggest a possible etiologic agent. Examples include the vesicular rash that is present in approximately 60 percent of neonates with CNS herpes simplex virus (HSV) disease (",
"    <a class=\"graphic graphic_picture graphicRef56041 graphicRef75059 graphicRef78598 \" href=\"UTD.htm?26/56/27529\">",
"     picture 1A-C",
"    </a>",
"    ), maculopapular rash in West Nile virus (WNV) disease (",
"    <a class=\"graphic graphic_picture graphicRef54623 \" href=\"UTD.htm?6/38/6756\">",
"     picture 2",
"    </a>",
"    ), the characteristic lesions of hand, foot, and mouth disease (coxsackieviruses A and B) (",
"    <a class=\"graphic graphic_picture graphicRef52800 graphicRef58566 graphicRef71314 graphicRef53423 \" href=\"UTD.htm?23/18/23850\">",
"     picture 3A-D",
"    </a>",
"    ), and the rash of Rocky Mountain spotted fever (",
"    <a class=\"graphic graphic_picture graphicRef58061 \" href=\"UTD.htm?39/20/40270\">",
"     picture 4",
"    </a>",
"    ), which typically does not appear until several days after the onset of fever. Other clinical findings that may suggest an etiologic agent are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef71744 \" href=\"UTD.htm?21/8/21645\">",
"     table 8",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies are performed to support the clinical diagnosis of encephalitis and establish an etiology, to assess for other conditions in the differential diagnosis (",
"    <a class=\"graphic graphic_table graphicRef62512 \" href=\"UTD.htm?12/2/12334\">",
"     table 2",
"    </a>",
"    ), and to look for potential complications (eg, inappropriate antidiuretic hormone secretion).",
"   </p>",
"   <p>",
"    Certain laboratory tests should be performed in all patients with suspected encephalitis (",
"    <a class=\"graphic graphic_table graphicRef63632 \" href=\"UTD.htm?16/39/17021\">",
"     table 10",
"    </a>",
"    ). Others should be performed when indicated by clinical findings or initial laboratory evaluation (eg, testing for arboviruses may be indicated depending upon the time of year and geographic locale).",
"   </p>",
"   <p>",
"    Potential laboratory clues to the etiologic diagnosis are listed below [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neutropenia &ndash; Colorado tick fever, ehrlichiosis, herpes viruses (neutropenia occurs predominantly in neonatal HSV; it is uncommon in older children unless they are overwhelmingly ill), measles, rickettsiae, rubella",
"     </li>",
"     <li>",
"      Thrombocytopenia &ndash; Ehrlichiosis, rickettsiae",
"     </li>",
"     <li>",
"      Eosinophilia &ndash;",
"      <em>",
"       Toxocara",
"      </em>",
"      ,",
"      <em>",
"       Trichinella",
"      </em>",
"      , and other parasites",
"     </li>",
"     <li>",
"      Hyponatremia &ndash; Rickettsiae, Eastern equine encephalitis virus",
"     </li>",
"     <li>",
"      Syndrome of inappropriate antidiuretic hormone secretion &ndash; St. Louis encephalitis virus, HSV",
"     </li>",
"     <li>",
"      Hypoglycemia, acidosis, abnormal pH,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      elevated ammonia &ndash; metabolic encephalopathy, inborn error of metabolism, toxic ingestion",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     CSF evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar puncture (LP) should be performed in all patients (unless contraindicated) with suspected encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/4\">",
"     4",
"    </a>",
"    ]. Neuroimaging is required before LP in virtually all children with suspected encephalitis because they have altered levels of consciousness. Magnetic resonance imaging (MRI) is preferred, but it is not usually immediately available. In practice, many children undergo computed tomography (CT) before LP to make sure there are no contraindications to LP (eg, mass lesion, shift) and MRI after LP because MRI is more sensitive and specific for encephalitis. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Neuroimaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An opening pressure should be documented (to provide a clue to conditions with elevated intracranial pressure that can mimic viral encephalitis (",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef69683 \" href=\"UTD.htm?8/25/8603\">",
"     table 11",
"    </a>",
"    )). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Samples of cerebrospinal fluid (CSF) should be sent for cell count and differential, glucose, protein, Gram stain, bacterial culture, HSV PCR, and enterovirus PCR; additional tests should be done as indicated by epidemiology and clinical findings (eg,",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    culture PCR for other",
"    <em>",
"     Herpesviridae",
"    </em>",
"    , WNV,",
"    <em>",
"     influenzae",
"    </em>",
"    , nonviral pathogens) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. CSF viral cultures are NOT routinely recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8,16\">",
"     8,16",
"    </a>",
"    ]. It may be helpful to freeze a sample of CSF for further testing (as indicated) if the diagnosis is not reached initially.",
"   </p>",
"   <p>",
"    The CSF indices in viral encephalitis are similar to those in viral meningitis and meningoencephalitis and may overlap with those of bacterial meningitis (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 4",
"    </a>",
"    ). In 3 to 5 percent of patients with encephalitis, CSF findings are completely normal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic CSF findings in viral encephalitis are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CSF pleocytosis is present in approximately 60 percent of children with encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6,17,18\">",
"       6,17,18",
"      </a>",
"      ]. The CSF white blood cell (WBC) count typically ranges from 0 to 500",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      with a lymphocytic predominance; however, a predominance of neutrophils can be seen during the first 24 to 48 hours of infection.",
"     </li>",
"     <li>",
"      Red blood cells are usually absent (except in traumatic tap), but their presence can indicate HSV encephalitis, La Crosse virus encephalitis, or other necrotizing encephalitides (eg, Eastern equine encephalitis, amebic encephalitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=see_link&amp;anchor=H10#H10\">",
"       \"Herpes simplex virus type 1 encephalitis\", section on 'Laboratory abnormalities'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4762?source=see_link&amp;anchor=H13571669#H13571669\">",
"       \"Free-living amebas\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Protein is usually slightly elevated (generally &lt;150",
"      <span class=\"nowrap\">",
"       mg/dL).",
"      </span>",
"     </li>",
"     <li>",
"      Glucose is usually normal and &gt;50 percent of blood value. Moderate reduction in glucose can be seen with HSV and mumps; marked depression, often &lt;10",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      occurs with tuberculous meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of more than 1500 cases of encephalitis, there was a wide range of CSF WBC counts and protein levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with infectious encephalitis had significantly higher CSF WBC compared to patients with noninfectious encephalitis (median CSF WBC 53.5 versus 9.5",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    but the difference in protein levels was not significant (median level 71 versus 67",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    Among patients with viral encephalitis, 83 percent had CSF WBC count &ge;6",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    and 32 percent had protein levels &le;45",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"   </p>",
"   <p>",
"    With the increase in diagnosis of autoimmune encephalitis, CSF and serum for antibody studies for N-methyl-D-aspartate receptor (NMDAR) and voltage-gated potassium channel (VGKC) may be warranted if clinically indicated (eg, adolescent females, patients who present with a predominance of psychiatric symptoms) or if initial viral testing is negative [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/11,12,21\">",
"     11,12,21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with suspected encephalitis should undergo neuroimaging [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/4,5,8\">",
"     4,5,8",
"    </a>",
"    ]. Neuroimaging in patients with encephalitis may be normal or may demonstrate brain edema and inflammation of the cerebral cortex, gray-white matter junction, thalamus, or basal ganglia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5,22\">",
"     5,22",
"    </a>",
"    ]. In prospective series of children with encephalitis, neuroimaging abnormalities were present at the time of admission in 30 to 37 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6,17\">",
"     6,17",
"    </a>",
"    ], and later during hospitalization in approximately 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI is the modality of choice; CT, with and without contrast enhancement, is an acceptable alternative, particularly in the emergent evaluation, if MRI is unavailable, impractical, unreliable, or cannot be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. In practical terms, because virtually all children with suspected encephalitis require neuroimaging before LP and MRI generally is not immediately available, many children undergo CT before LP to exclude contraindications, and MRI after LP. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'CSF evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    MRI is superior to CT in early detection of encephalitis on T2-weighted images, but in neonates and infants, a diffusion-weighted image (DWI) appears to be more sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. MRI can detect early changes and has, on occasion, led to presumptive diagnosis of HSV encephalitis when HSV PCR was negative on the initial CSF analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/25\">",
"     25",
"    </a>",
"    ]. MRI also detects other conditions that are in the differential diagnosis of encephalitis, such as acute disseminated encephalomyelitis (ADEM), head trauma, intracranial hemorrhage, and tumor (",
"    <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Specific conditions in the differential diagnosis may be suggested by neuroimaging findings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5,7,8,22\">",
"     5,7,8,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HSV &ndash; Temporal lobe localization (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80797 \" href=\"UTD.htm?29/14/29921\">",
"       image 1",
"      </a>",
"      ); temporal localization also may occur with other herpes viruses and syphilis",
"     </li>",
"     <li>",
"      Flavivirus, Eastern equine encephalitis virus &ndash; Lesions in the thalamus, basal, ganglia, and midbrain that are of mixed intensity or hypodense on T1 and hyperdense on T2 and fluid-attenuated inversion recovery (FLAIR) images",
"     </li>",
"     <li>",
"      Enterovirus 71 encephalitis &ndash; Hyperintense T2 and FLAIR lesions in the midbrain, pons, and medulla",
"     </li>",
"     <li>",
"      Respiratory virus encephalitis (eg, influenza, parainfluenza, adenovirus, respiratory syncytial virus) &ndash; Abnormalities in the thalamus or basal ganglia",
"     </li>",
"     <li>",
"      Postinfectious encephalitis (ADEM) &ndash; Foci of demyelination in the semilunar white matter, basal ganglia, or spinal cord (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76694 \" href=\"UTD.htm?8/46/8935\">",
"       image 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Congenital infection (eg, toxoplasmosis, cytomegalovirus) &ndash; Intracranial calcifications (better detected with CT) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef69239 \" href=\"UTD.htm?29/12/29902\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <em>",
"       Balamuthia mandrillaris",
"      </em>",
"      &ndash; Space-occupying lesions or unifocal or multifocal ring-enhancing lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Electroencephalogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Every patient with suspected encephalitis should undergo electroencephalography (EEG) as soon as is feasible; however, EEG is not usually obtained as part of the initial evaluation in the emergency department or other acute care settings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ]. EEG may help to differentiate encephalitis from nonconvulsive seizure activity (ie partial complex seizures, absence seizures). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=see_link\">",
"     \"Clinical features and complications of status epilepticus in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the findings are nonspecific, EEG is abnormal in 87 to 96 percent of children with encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6,17\">",
"     6,17",
"    </a>",
"    ]. A temporal focus suggests",
"    <em>",
"     Herpesviridae",
"    </em>",
"    encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=see_link\">",
"     \"Herpes simplex virus type 1 encephalitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with encephalitis are diagnosed clinically (ie, without brain biopsy). Clinical diagnosis requires evidence of neurologic dysfunction (eg, depressed or altered level of consciousness, lethargy, personality change, seizure, ataxia, focal neurologic findings) and CNS inflammation (CSF pleocytosis; consistent neuroimaging or EEG findings) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/6,7,16,26\">",
"     6,7,16,26",
"    </a>",
"    ]. Other causes of altered brain function must be excluded.",
"   </p>",
"   <p>",
"    The case definition for acute encephalitis varies from study to study. In the California Encephalitis Project, encephalitis was defined as encephalopathy (depressed or altered level of consciousness for &ge;24 hours, lethargy, or change in personality) requiring hospitalization, PLUS at least one of the following: fever, seizure, focal neurologic findings, CSF pleocytosis, or EEG or neuroimaging findings consistent with encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Etiologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to identify a specific etiology, if possible, in patients with encephalitis, for treatment, prognostic, and public health purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causative viral pathogen may be identified through testing of the CSF (eg, PCR, IgM)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    testing of anatomic sites other than the CNS (eg, serology) (",
"    <a class=\"graphic graphic_table graphicRef63632 \" href=\"UTD.htm?16/39/17021\">",
"     table 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. Skin biopsy assists in the diagnosis of rabies. Brain biopsy may be employed as a last resort in patients who continue to deteriorate despite",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    The United States Centers for Disease Control and Prevention (CDC) should be notified when certain pathogens are isolated from patients in the United States. An updated list of these pathogens is available from the",
"    <a class=\"external\" href=\"file://www.cdc.gov/osels/ph_surveillance/nndss/nndsshis.htm\">",
"     CDC",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CNS studies &ndash; Tests of the CSF that can help to establish an infectious etiology for encephalitis include antibody testing and PCR [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ]. The detection of virus-specific IgM in the CSF usually indicates CNS disease because IgM antibodies do not readily cross the blood-brain barrier. CSF PCR testing for particular pathogens is helpful when positive, but negative tests do not necessarily exclude the pathogen [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ]. Additional caveats regarding CSF PCR testing for specific pathogens are provided below:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For HSV-1 encephalitis, CSF PCR is the diagnostic test of choice. It is highly sensitive and specific [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ]. However, HSV PCR may be negative during the first few days of illness [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/25,27\">",
"       25,27",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=see_link&amp;anchor=H15#H15\">",
"       \"Herpes simplex virus type 1 encephalitis\", section on 'Polymerase chain reaction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Enterovirus CSF PCR does not permit identification of the enterovirus serotype. Enterovirus 71, an important cause of encephalitis in young children, is rarely detected by CSF PCR. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H20#H20\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Polymerase chain reaction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A positive EBV CSF PCR does not absolutely indicate CNS infection because latently infected mononuclear cells in the CSF can cause a false positive result [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Brain biopsy should be the last resort. It may be indicated if a patient with encephalitis of unknown etiology continues to deteriorate neurologically despite",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Non-CNS studies &ndash; When the pathogen is identified from an anatomic site other than the CNS, the results must be interpreted in conjunction with epidemiologic findings, clinical findings, and other diagnostic study results (",
"      <a class=\"graphic graphic_table graphicRef57122 \" href=\"UTD.htm?22/25/22941\">",
"       table 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73833 \" href=\"UTD.htm?21/49/22300\">",
"       table 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef71744 \" href=\"UTD.htm?21/8/21645\">",
"       table 8",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ]. The isolated pathogen may play a role in the CNS manifestations, but not necessarily by direct invasion, or may be present but unrelated to encephalitis (eg, hepatitis C, rotavirus,",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Acute and convalescent antibody titers may be helpful if cultures and PCR have not established a diagnosis and the patient remains ill. Detection of antibodies in acute serum may be helpful in identifying some pathogens (arboviruses, HIV, rabies) and may be used as evidence of causation if the infection is rare or highly fatal (eg, rabies, Eastern equine encephalitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/16/21769/abstract/5,8,28\">",
"       5,8,28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Presentation and DDx",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Encephalitis causes neurologic dysfunction and has a broad range of presenting symptoms and signs. The clinical manifestations vary depending upon which portions of the central nervous system (CNS) are affected, the etiologic agent, and various host factors (eg, age, immune status). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In neonates and young infants, encephalitis can present with fever, seizure, poor feeding, irritability, lethargy, or sepsis. Fever is a variable finding. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Neonates and young infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In older children and adolescents, encephalitis can present with fever, psychiatric symptoms, emotional lability, movement disorder, ataxia, seizures, stupor, lethargy, coma, or localized neurologic changes. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Children and adolescents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of encephalitis is broad (",
"      <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"       table 3",
"      </a>",
"      ). It may be narrowed through history, examination, laboratory, and radiologic evaluation. Autoimmune encephalitis is an increasingly identified noninfectious etiology. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation of the child with suspected encephalitis begins with assessment of the airway, breathing, and circulation. The first priorities are stabilization of cardiorespiratory status and management of seizures (",
"      <a class=\"graphic graphic_table graphicRef51779 \" href=\"UTD.htm?19/29/19933\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=see_link\">",
"       \"Initial assessment and stabilization of children with respiratory or circulatory compromise\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link&amp;anchor=H34#H34\">",
"       \"Management of status epilepticus in children\", section on 'Initial pharmacologic therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After the child is stabilized, the evaluation includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      History and examination (",
"      <a class=\"graphic graphic_table graphicRef57122 \" href=\"UTD.htm?22/25/22941\">",
"       table 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73833 \" href=\"UTD.htm?21/49/22300\">",
"       table 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef71744 \" href=\"UTD.htm?21/8/21645\">",
"       table 8",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H15\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Examination'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Initial laboratory tests (",
"      <a class=\"graphic graphic_table graphicRef63632 \" href=\"UTD.htm?16/39/17021\">",
"       table 10",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H17\">",
"       'Laboratory evaluation'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Neuroimaging (magnetic resonance imaging [MRI] is preferred, but because it is generally not available in the acute setting, many children undergo computed tomography before lumbar puncture [LP] to exclude contraindications, and MRI after LP) (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Neuroimaging'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Electroencephalography (EEG) (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Electroencephalogram'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The goals of the evaluation are to define the clinical syndrome (eg, acute encephalitis, postinfectious encephalitis, autoimmune encephalitis, meningitis, toxic or metabolic encephalopathy, etc) and to identify a specific etiology (",
"      <a class=\"graphic graphic_table graphicRef62512 \" href=\"UTD.htm?12/2/12334\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"       table 3",
"      </a>",
"      ). It is particularly important to consider etiologies that require specific therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical diagnosis of encephalitis requires evidence of neurologic dysfunction (encephalopathy) and CNS inflammation (eg, cerebrospinal fluid (CSF) pleocytosis, findings consistent with encephalitis on neuroimaging or EEG). Other causes of altered brain function must be excluded (",
"      <a class=\"graphic graphic_table graphicRef68501 \" href=\"UTD.htm?6/11/6334\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Clinical diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causative viral pathogen may be identified through testing of the CSF (eg, polymerase chain reaction, IgM antibodies)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      testing of anatomic sites other than the CNS (eg, stool culture, serology). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Etiologic diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/1\">",
"      Whitley RJ. Viral encephalitis. N Engl J Med 1990; 323:242.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Shields WD, Bronstein DE. Encephalitis and meningoencephalitis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.504.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/3\">",
"      Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/4\">",
"      Thompson C, Kneen R, Riordan A, et al. Encephalitis in children. Arch Dis Child 2012; 97:150.",
"     </a>",
"    </li>",
"    <li>",
"     Glaser C, Long SS. Encephalitis. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG.  (Eds), Elsevier Saunders, Edinburgh 2012. p.297.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/6\">",
"      Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis 1998; 26:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/7\">",
"      Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/8\">",
"      Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/9\">",
"      Centers for Disease Control and Prevention (CDC). Primary amebic meningoencephalitis--Arizona, Florida, and Texas, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/10\">",
"      Schuster FL, Yagi S, Gavali S, et al. Under the radar: balamuthia amebic encephalitis. Clin Infect Dis 2009; 48:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/11\">",
"      Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/12\">",
"      Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/13\">",
"      Bseikri MR, Barton JR, Kulhanjian JA, et al. Anti-N-methyl D-aspartate receptor encephalitis mimics viral encephalitis. Pediatr Infect Dis J 2012; 31:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/14\">",
"      Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/15\">",
"      Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/16\">",
"      Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003; 36:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/17\">",
"      Fowler A, St&ouml;dberg T, Eriksson M, Wickstr&ouml;m R. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol 2008; 12:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/18\">",
"      Galanakis E, Tzoufi M, Katragkou A, et al. A prospective multicenter study of childhood encephalitis in Greece. Pediatr Infect Dis J 2009; 28:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/19\">",
"      Balfour HH Jr, Siem RA, Bauer H, Quie PG. California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics 1973; 52:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/20\">",
"      Przelomski MM, O'Rourke E, Grady GF, et al. Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984. Neurology 1988; 38:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/21\">",
"      Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/22\">",
"      Beattie GC, Glaser CA, Sheriff H, et al. Encephalitis with thalamic and Basal Ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 2013; 56:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/23\">",
"      Maschke M, Kastrup O, Forsting M, Diener HC. Update on neuroimaging in infectious central nervous system disease. Curr Opin Neurol 2004; 17:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/24\">",
"      Teixeira J, Zimmerman RA, Haselgrove JC, et al. Diffusion imaging in pediatric central nervous system infections. Neuroradiology 2001; 43:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/25\">",
"      Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002; 34:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/26\">",
"      Huttunen P, Lappalainen M, Salo E, et al. Differential diagnosis of acute central nervous system infections in children using modern microbiological methods. Acta Paediatr 2009; 98:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/27\">",
"      Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007; 119:e399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/16/21769/abstract/28\">",
"      McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001; 344:801.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6042 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.13-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21769=[""].join("\n");
var outline_f21_16_21769=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      VIRAL ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Postinfectious",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14169267\">",
"      Autoimmune encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Toxic-metabolic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Intracranial pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      APPROACH TO DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - CSF evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Electroencephalogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Etiologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Presentation and DDx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6042\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6042|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/14/29921\" title=\"diagnostic image 1\">",
"      HSV encephalitis MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/46/8935\" title=\"diagnostic image 2\">",
"      MRI of boy with ADEM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/12/29902\" title=\"diagnostic image 3\">",
"      Congenital CMV cranial CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6042|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/29/39382\" title=\"picture 1A\">",
"      Neonatal HSV scalp vesicles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/3/4159\" title=\"picture 1B\">",
"      Neonatal HSV neck vesicles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/44/28367\" title=\"picture 1C\">",
"      Neonatal HSV eye vesicles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/38/6756\" title=\"picture 2\">",
"      WNV fever and rash",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/12/4293\" title=\"picture 3A\">",
"      Hand-foot-and-mouth disease - lip and hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/2/13344\" title=\"picture 3B\">",
"      Hand-foot-and-mouth disease - buccal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/27/20912\" title=\"picture 3C\">",
"      Hand-foot-and-mouth disease - tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/22/14689\" title=\"picture 3D\">",
"      Hand-foot-and-mouth disease - foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/20/40270\" title=\"picture 4\">",
"      RMSF rash",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6042|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/29/19933\" title=\"table 1\">",
"      Evaluation and management of suspected encephalitis in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/2/12334\" title=\"table 2\">",
"      Meningoencephalitis infxs causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/11/6334\" title=\"table 3\">",
"      Viral encephalitis mimics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 4\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/6/44140\" title=\"table 5\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/25/22941\" title=\"table 6\">",
"      Epidemiologic and historic clues encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/49/22300\" title=\"table 7\">",
"      Encephalitis travel history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/8/21645\" title=\"table 8\">",
"      Encephalitis clinical clues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/58/2989\" title=\"table 9\">",
"      Glasgow and pediatric coma scales",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/39/17021\" title=\"table 10\">",
"      Initial labs encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/25/8603\" title=\"table 11\">",
"      Causes of elevated ICP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=related_link\">",
"      Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22506?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31590?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Pathogenesis and etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/18/23848?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=related_link\">",
"      Clinical features and complications of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4762?source=related_link\">",
"      Free-living amebas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=related_link\">",
"      Herpes simplex virus type 1 encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=related_link\">",
"      Initial assessment and stabilization of children with respiratory or circulatory compromise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=related_link\">",
"      Management of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/56/906?source=related_link\">",
"      Paraneoplastic and autoimmune encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38968?source=related_link\">",
"      Viral encephalitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_16_21770="Subpulmonic effusion I PA";
var content_f21_16_21770=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57250%7EPULM%2F75184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57250%7EPULM%2F75184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right subpulmonic pleural effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph of a right subpulmonic pleural effusion. The right lung base is slightly elevated. A small pneumoperitoneum outlines the actual level of the right hemidiaphragm. Left pleural effusion has spilled over into the left lateral costophrenic sulcus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1115px;\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Subpulmonic pleural effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: Right subpulmonic pleural effusion in patient after mediastinal irradiation. The right lung base is elevated as well as the right hilum. Right panel: After thoracentesis, a residual hydropneumothorax with a large right sided gas-liquid level ensues, thus proving that the elevation of the right lung base was not due to an elevated right hemidiaphragm but to a subpulmonic pleural effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21770=[""].join("\n");
var outline_f21_16_21770=null;
var title_f21_16_21771="Classification angiodysplasias";
var content_f21_16_21771=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of gastrointestinal angiodysplasia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Location",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duodenal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jejunal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ileal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colonic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Size",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minute (&lt;2 mm in diameter)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intermediate (2 to 5 mm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large (&gt;5 mm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Number of lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unique (n = 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple (n = 2 to 10)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diffuse (n &gt;10)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     As an example. \"J - S2 - N2,\" signifies multiple angiodysplasias of intermediate size in the jejunum.",
"    </div>",
"    <div class=\"reference\">",
"     Proposed by the European Endoscopy Club in: Schmit A, van Gossum A. Proposal for an endoscopic classification of digestive angiodysplasias for therapeutic trials. Gastrointest Endosc 1998; 48:659.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21771=[""].join("\n");
var outline_f21_16_21771=null;
var title_f21_16_21772="Nasal irrigation for atrophic rhinitis";
var content_f21_16_21772=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F78832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F78832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Handout for nasal irrigation for atrophic rhinitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Buffered normal saline nasal irrigation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        The benefits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. When you irrigate, the saline (saltwater) acts as a solvent and washes the mucus crusts and other debris from your nose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. The sinus passages are moisturized.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Studies have also shown that a nasal irrigation improves cell function (the cells that have fine filaments to move the mucus out work better).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        The recipe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Choose a one-quart glass jar that is thoroughly cleansed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fill with water that has been distilled, previously boiled, or otherwise sterilized.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Add 1 to 1 1/2 heaping teaspoons of pickling/canning salt, NOT table salt, as it contains a large number of additives.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Add 1 teaspoon baking soda (pure bicarbonate).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mix ingredients together and store at room temperature. Discard after 1 week.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        The instructions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        You should plan to irrigate your nose with buffered saline two to three times per day. You may use a bulb/ear syringe, large medical syringe (30 cc), or water pick with an irrigation tip. Always pour the amount of fluid you plan to use into a clean bowl. DO NOT put your used syringe back into the quart because it contaminates your solution. Many people prefer to warm the solution slightly in the microwave, but be sure that the solution is NOT HOT. Bend over the sink (some people do this in the shower) and squirt the solution into each side of your nose, aiming the stream toward the back of your head, NOT the top of your head. It will not harm you if you swallow a little.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Some people experience a little burning sensation the first few times they use buffered saline solution, but this usually goes away after they adapt to it.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        After irrigating, apply a lubricant (such as petrolatum or KY liquid) to the inside of the nose with a clean cotton swab. If told to do so by your health care provider, you may apply mupirocin ointment instead (also with a cotton swab).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Diseases of the Sinuses: Diagnosis and Management. Kennedy DW, Bolger WE, Zinreich SJ (Eds), BC Decker, Hamilton, Ontario 2001. Copyright &copy; Kennedy DW, Zinreich SJ.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21772=[""].join("\n");
var outline_f21_16_21772=null;
var title_f21_16_21773="Organic cation secretion";
var content_f21_16_21773=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F52320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F52320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proximal organic cation secretion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 311px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Model for organic cation (OC+) secretion in the proximal tubule. Entry into the cell occurs in part by passive carrier- mediated diffusion across the basolateral membrane down favorable concentration and electrical gradients created by the Na-K-ATPase pump. Secretion into the lumen occurs by a H+-OC+ exchanger that is driven by the H+ gradient created by the Na+-H+ antiporter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21773=[""].join("\n");
var outline_f21_16_21773=null;
var title_f21_16_21774="Superior sulcus tumor survival";
var content_f21_16_21774=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Published treatment results in patients with superior sulcus tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total number of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of treated patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median survival, months",
"       </td>",
"       <td class=\"subtitle1\">",
"        Five year survival, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Preoperative",
"radiotherapy + surgery &plusmn; postoperative radiotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kirsh 1973",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1974",
"       </td>",
"       <td>",
"        116",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Miller 1979",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stanford 1980",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ahmad 1984",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Paulson 1985",
"       </td>",
"       <td>",
"        131",
"       </td>",
"       <td>",
"        78",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        31",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Devine 1986",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anderson 1986",
"       </td>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Beyer 1986",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        48",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1987",
"       </td>",
"       <td>",
"        129",
"       </td>",
"       <td>",
"        82",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Shahian 1987",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        56",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neal 1991",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sartori 1992",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Maggi 1994",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        7 to 19",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ginsberg 1994",
"       </td>",
"       <td>",
"        124",
"       </td>",
"       <td>",
"        124",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        26",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Attar 1998",
"       </td>",
"       <td>",
"        105",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        21.6 months",
"       </td>",
"       <td>",
"        27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        Komaki 2000",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        143",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        143",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        47 (stage IIB)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14-16 (stage III)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Surgery +",
"intraoperative/postoperative radiotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1971",
"       </td>",
"       <td>",
"        106",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1974",
"       </td>",
"       <td>",
"        116",
"       </td>",
"       <td>",
"        57",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Attar 1979",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        7 (3 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1987",
"       </td>",
"       <td>",
"        129",
"       </td>",
"       <td>",
"        46",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Primary radiotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kirsh 1973",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hilaris 1974",
"       </td>",
"       <td>",
"        116",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Attar 1979",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        7 (3 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Komaki 1981",
"       </td>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ahmad",
"1984",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        VanHoutte 1984",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anderson 1986",
"       </td>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neal 1991",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Preoperative chemoradiotherapy +",
"surgery + intraoperative radiotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Martinez-Monge 1994",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        56 (4 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Attar 1998",
"       </td>",
"       <td>",
"        105",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        72",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wright 2002",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        84 (4 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Suntharalingam 2000",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rusch 2003",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        41",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Several studies have included patients that were treated with different treatment modalities, such as primary radiotherapy versus combined radiosurgical treatment, and therefore, those studies were listed more than once under different treatment groups.",
"     <br>",
"      * The percentages indicate reported 5 year survival rates unless stated otherwise.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21774=[""].join("\n");
var outline_f21_16_21774=null;
var title_f21_16_21775="Holoprosencephaly brain section";
var content_f21_16_21775=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Holoprosencephaly on brain section",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 291px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEjAVgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5X2+9G2nUUAJt96NnvTqKAGbfejb70+igBu33o2e9OpaAGbPejZ70+loAZs96NnvUlJQBHs96NnvUlGKAGbPelEZJ608Crun2Ut5cRwwIWdztAxSGk3sUlt2PerlrpNxcuFhRnJ7AV6d4f+G88uwzr5jnsvAH+NeteHPh9DbRqZEUcDgDFZOpf4TpWHUVeo7Hz3p3gHUrvbkKgPrmumtfg9qMyqTcxKCO6GvpSx8PW9uoCxqMe1aK2MargAUR5upMnSWkUfLtx8G9QiBzdRkj/YP+NY978Mb+2zmVD/wE19byWUWR8ox2rPu9IhmByq8juKp36MUXT6o+NtT8JX1kMkBx/sg1hy2jxnD8GvsLV/B8N0CQq59q868a/DktYPJEqLIvIb/GoVRp6mro05r3HqfPhi9xSbPetbVdNn0+4eKdNrLWcRWydzllFxdmQ7Pel2e9P+lFMkj2e9Gw1JSfWgBmz3o2U+igBmyjZ70+igBmz3o2+9PoNADNvvSbfen0UAM2+9G33p1FADdtG3jrTqKAGlfeinUUAFFBoFAC0UCigAooo70AFOpBS0AApaAKcBnFACYoxUioSOBTvKb+6aB2ZDigDmpjC3XaaTYc9KA5WLBE0siogyzHAAr3X4Y+D0jEcjoGmbG5sdPYV41ocf8AxM7bPTeDX1P8PvKSwTn5jWNR3aidlCPLBz6nV6ZpC26qAgCjpW4iCNeOB7UkDccc0+QE4I6intscspOT1Fzjpnk1DO4w3OBimTthetYt9qCwyfexjt6VLlbccKfNsaiyYj5NCnII5PHc1zq6tFuwJB16ZrStLpZR8p/GkpXNZUnE08KcgnJNZmsWwltXQqCrCrkco69cdMU6dQ8Rz0PY03qiI+67nzz8SPDm6Odkj5AJQ45+leKzRlHKsMEV9b+M9NNxYTlBucKcCvmHxPaNb6nKpXBJzxSpOz5TpxEVOCmjAxzSYqbYfSk2HPQ1ucNiIjmkxUpQ+hpNpFAiPFGKdtoIpgNopaSgBKKXFJQAlFLRQISijvRQAlFFFAwooooAUUUgpaACiiigAxSikFLQAU4CkFTRoWIAoAREJ7VsaRoN7qbhba3dxn723iux8CeDftqx3F4hIY/Kh9PU17t4b8N21rBGBGAfasnO7tE6o0VFc0zyLQvh28cSmeHfIepI4rWn8CFUJFqv5V7lDZIi4CjinvbIyHAHHtWbg31NI4iMdEtD5g1nwg0IJWJo/wDgPFchqOjT25JCsVHtX1pqOlw3IeJ1BIFcB4j8JFVkaNAVx2pKUomtqdXyZ4DpimO/hyCDuHWvor4fX6rGqO2ScYrybV9CMcmQm0qcgiuh8Lai1vdJkkc4IpuV2mVTp8sXE+jLW5VlVsgfSrAkJPbHrXI6TfiSEfMOnHNb6XG4c8jArU4ZU7MlupAF6DA964PxHMy3BKE47iupvphywyAfWuJ192aVgeRWFTU6sNHUyWvGSUYPPSun8PXu8YYiuCuG+c81t6HMQMbhWcXqdlSF4npttLvJI7DvUj3IXjHHTAFYWk3Bd2Gd3FbSRfMHOc+npW6ba0PNnFRepn63GX0u4Zc7whCr357183eL9CuZr9nVGPOOlfUkiKUwBkVh3Oi291JtkiTaSCSV54ocWndF06keVxkfNFr4Quif3qMPYCtuDwG8ij9w5JHYGvoB9It8nCDjgDFXra2hUfdAwMdKfvN6sHKmloj5xf4fXKsdsMh+q1Tn+Hl6f9VHID/tIa+pPIi3KDjNWFtogckLj1ppPuZSqw/lPkO4+H+tR/ctTIvYr/8AXrn9T0O/059t5aTQn/bQjNfb5sIm6ovPrVO+0O1uoGjlijdT/C6gg/hVaoycoPyPhh4yvUVGRivffir8LhDGdQ0KAg5/eW6DjHqv+FeHXVq8DssilWBwQRjFOM09BShbXoUT9KDT2BFNqyBtJSnpSUAFFFFABSUGikAtFJRTAXj1ooFFAB3oopRQAUtIKcBQA5RzXoXw28Oi+nF5cR7oUOEBHBauEtYjJKqAck4r6P8Ah/piWunWsYXIVB2xn1rGrKysjrw1O75n0O08M6WkNsmY/wBK6e2j2MUVCoUA5I4OewqDTYdkYKkgY4HpWogOOfpxSitDOrNuQ0gkZPyjFMnIVVHqakZscNwOlRyFQAScrnoaTIRXWAfM/r7VTv4C0LAgYPqK1lYOvGPeoLgZGACATg+1NaItSdzzrW9Hjfd+7GD7dK5tvDpikDovGeK9XubRH4Kj1qqNPTcCFwM8UrJnXGtoYmgWzxoEkzjGceldTEpCAAHmmQ2+B9wAVeRCuMYqzCpO7uZ99AWBzyO2K5XWLfMZBGT1PrXZXYAQ571yutHEZ9TWUzWhJnAX0e2cgGrmlEg45IPeoNSIM/H51FazsjYrG9mei9Ud3om4zAlucdK7S2+YAYOcV55ol0NwyeRXc6bchgAT7itoM87Exe5pGPA9uwqKVdoJAq9HtbBJpxjU7vetrHDzWMYLujBxz70sSEZJ71oeWoyAAPxpjKFGOnvU2L5yqUJmU4457VYQEA4/GobiXYpIJyPSqZuyRw3epukPlcjYjZlQ5zx1z61ZjOQM9ax4bvCgZ96v2028EjHBoUiJQsWZoUlUhwCD6ivOfid8OrXxFpcr2UMMWop80cgUAt/skivSI39+cU4AOpB6VVkyFJxPgrWtNn028ltrqJo5o2KspHQ1lsK+svjb4Ft9Y0CbULC2T+04Pn3IMGRB1B9eOfwr5VuYjG5BBBFXGV9HuU11RVpKdim1ZIUlKTRQAlFFFIBKKKKAFooooAWkpRRTAUU9ByKaoya2bTTwqCSYc9hSbsVGLkzf+HGhHVNZXep2RLvP9K+k/DGmC2tkyOo6mvP/AIS6dDY6YLl8M90QRx0AzxmvWrORM4GOO1YaSkdjvCHKjThGxRtAzUweTkbOD71GhBB7ins3AIIq2jkK925C8DnrzWDLrO2doZsBh0NbtwcrzjHrXKeIbZZQGXgg5zWFS+6OuhGLdpGxYaiGlx7dQa196yxjPX27V5rp13JBNtY811Gl6hkEMw3MfWphPoy61C2qNeZZnUCMjO7DbvTvj/Pera267apRzq2SCOf0qVboKp+YHFappHM07WLIiAAx+VK6hV46VA1yuAQwyB0qleaisaEmm5JCUJNjdRmAV8nkdOa4fW73LEA8Y61c1fWfMZsMMe1cdqV0ztwePWsZTuejQo8u5WvLjL9unaqQnOahumx1PNUWuArjnipOk6bTNRaNxzXd6Dq+51ViBxXlFtcKW4IwK6GwvHiKsp5p3sROCmj2e1vt20Z61bN0CM54x1rzHTdblVVyyn8K1013gqxXNbKoedPCu5v65qz2sGLYB52ICL6n3q9A5MKmYruIGT2rjhcrPeJIz529PSuhhu0ZQAQcVMW27sU6fLFJIn1CdUXPGKy2kyRxyfSpruVSADjJ65qo5+bjgdOO1S27lQjZFi23swA6ZrZhfyk5OPXtWdahegGWHOTUl0plUAY9ORmqWiuRL3nY2LScyAsemavRt9PxrI05SEXzCMntVwpP9ogMcoSBVYuu3JY8Y59Ov6VotjmmleyJ71POgZCMgjpXy58YvAsml3lzqllCRZu+XAHCEn+VfUyYK5Jzn8jWP4n0e11bR7qyuxmKdCjY7e4pNO6kiqckrxa3PhR12nBqKuj8ZaI2h65dWTHIichW9R2Nc6etbRakromUXF2Y3HPNJTjTcUyQpKU0UAIKKWigAooooAUUCilA5pgamh2X2q5Bb7icn3ravXw2B0qXQbYw2AbHLjJqC7X95g1lJ6ndThyxue9fCUx3PhO1V1H7pm6/zrv0UKMpn04FcV4CeFNItEjGMRL0+nNdpG5GAuce1THuFRNOxftySvPHvU4IJ9QKigIKDsB6VNkL7A+1Wcr3K9zgA7umK53WJRswSAfTFdHc/MMiuF8Us7KVVXBU5D9ifSsKux1YZczMW/mCHegwRUVjrZWUqw2sO+etZt9OxQhhhh1rHacb8gYYVij03FW1PQIddfP3uAPWpRrTs2SeD6VwsF5gjrmrqTSPJhec0Mj2UTtk1htnDBh06c1n3t7NIG5IB+tUrEE7QcnirN69vaJvvJQPRB1NGrI5Yxehz2oPdHmCLe24DBOOPWqd3F5Z/fSgDFP1TX0YFLZSi/3icmuXu9QeaR8klh3pqJpzWJL+9gicgBmxx1xWDeavHux5Z9vmp9yjSsTWLf27rJGzD5c81rGBjOo+h0Wl38G/95uTPrzXWWDLJzDKHJ7DrXnsEDqAauQ3M9qdyMQR6Gk4XHGrbc9GSYxgDPI4ANCXjbuv41yFl4rA2pdoZF6bh1FdBazQXdv51pJuXoVPUfhUOLRopKRrLqbowG79a1INcdSNx61yG/MmMdKtsG25xQmEoJnYrrjSsFHGTzWlDeqUB3ZY/rXm0N08cjHkHNa1pqLHbnoKdzN0l0PQY7sDaQ2CeMeprWsZN65bn0riNNuvOkGeBXX2TqEUfzqoPU5a0LGykhjUZbrxUySkLk+naqaHOMcelXYCDjHHvWy1OKSsSwSswyV2g+9NugzxMoxyOfWpME8DAprAEHHy570mtLE31ufOXxl8MvJcTX6Kd6jnA6ivEJFwa+2PGOiLqOnTLgbivU+uK+UfGfhybR7skqfKY8cdD6VnRlyP2cjrqr2sFUj8zkSOaaakZcE0w11nGNo7UtIaACiiigApe9JS0AAqWBd0qD1OKiqxZj/SY8f3hQNbnpVtbhLJFx/CP5Vh6lGBKdufxroRLGIRuZBhRwD7Vz1/IskmVIrne56i0ieueALvFvbIf+eaj68V6dbEbQfWvIPAwwYQOwHSvWLQOIkbaT60oMnELY2Y0BTcGIyMdatpGcKRyBTLVMxjIHI71djjwmCBx6VqefKRTdMLjFcr4nRTEScdc111zgKc8Yrg/Fc6iM+U4Pbg5rKpsdOG1keeazIAzbfWufaQl8CtDVZ9xb16VmpGXbisEeqaFihYjnGK6SxQZCL+Oa5m2k8pgp60/UNY8hDHbv8AvCMMR2ppXYpPlR0epa/a6bE0dsfOuBxn+Ff8a4u51Sa7ld5GZmJ5zVJGLMSxzUoRfTFa8pze07DWJYEk1RldYZvnJw/etBjgdqz74xScORinYnmL0KKwzwap6hb/AGqdLaFdzZyx7AVUtrooDH5yBQfvFugrZ024srdCftEZLHJZnHNFmLmRaTTAsYGM9qq3OnkA8Vr/ANqWQQf6TCB/vio5rqGdD5ciN9GzVWE2jlbixKkkDBp1it1byK8TkEGtaYDODimBUHp9KQr2NrTLuG5kUTfu5TwfQ100lqRFnA6V53OcHKdfWu88Ha3balGunX8qR3gwsbOcCT2z61lOm90bRrdyi1k5diV4zxSGNo2A9K666s2tUKSLhRnJNYs1vuJYDjHArJPubqSewum3RjIXvXY6fqAaPGSO2fSuB2tC5LVq6dcqDy2MGtEzKpDmPR7O5U/KT9K04ZVMmFbgcY9a4OG+ZUAjzuPGa6PSHO1ec5559a2i3scFWlZXOo3ZoGScj65qC1Ybct0FWGdVGXwPetGjkGbSykNz2rjfGngm212wkieNVZh8rDsa7RSc5/HmpMceoPbpWbpqW5cKkoPQ+FvE+h3OiapcWV2hWWJiPY+4rDYc19X/ABi8B/2/pr3tlEPt8AJXHWRfQ+9fLF5A8E7xyKVdCQwPY1pCV9HuE0t1sVSKSnGm1oQFFFFIA70ooFKBmmADrVi0DecjAcg5qW2snbDOCF+lX0tdgyKhyNoUm9WWxcsRyxqayie7mCR9fU1mDLPj3r0PwjoMmI/3TGR8FuOgrKb5UdtJObt0Ox+H1vGJFWVtjKOM969csbVsAqeOxrltK8MxiGMyId4HX0rsNNhmtIwgy8Y/MU4KyMsRNS2Zo2qMow34e9WSuFzzn+VEbAqM5/Klcrszuqzhb1KV9jYc88HNeVeOJAkpaM/MT82O9ek6pOFjbPGM15R4pk8yckHjOKwqy6Ho4KGtzjZV8xiSCc04IFX0NXDGNhPQ1UkdIFaaY4jQFiaxWp6T0M+/uFtkbLfvDworDEozktWTq+uG6u3kUHZnCj0FZbalL2xXXCFkeXVr80jrY50Vic8HnrTJ9Xt4AdzjPoOa4yW7ml4ZyB6CoCxq1AxdbsdBf+IHkBWAbc/xGsOW4llYl5GJ9zUX1pKaSRlKbkOLk96XefU0yimTdj959TUsN1NC26ORlI9DValosHMzbh8QXS4EpD+/etS11yGXAZtrf7VchRnFLlRaqtHdm8DD7w59DVWS5Ik3o2COciuUiuHiPysfpU4vWPXrS5S/an0p4R1618XaPFBIwXU4VxJH/wA9MY+cf1p89qYpmSQEjkcV896Hrt3pOoQ3llK0U8ZyrCvo/T54tc8N2WpRyrI80QaXYfuvj5h7c5rCrS+0jooVre6zn721JcYyR0qmv7piB2roEtbqYM0UE0kfTcqkgfjWXd2FyDlbabB77DzWcUdfMtiewnbIP8RPf0rudGcNGN36GvPra3uUkG+CVcc8of8ACuj0y8eMgBSAvqCMVvBdTmre8tD0KFlxhfSp1IbjpjpXO2l8u0HdzjGDWjbXis2cjd9a1PPlFo1QoJPHXvin5Ct0J4qsLhMD5h9PWrCyA9COalkEdzGGiI/iPc18g/GLQ5dL8X30jRFYbhzKhxwc9f1r7F3qenXsa8r+NPhn+1rMXKqWMS4OB0HrWUnyNSN6K57wfU+TGByaaav6paNaXs0JydjEZxVE8GuhO5lJOLsxtFFFMQoFbPh7Tzd3O4j5EGT9ay7aJppkjQZZjjFeo2OnJp2kom0ZI+Y+pqJysjehT55HPXEQ3YA4FV5gFQ1tSRbmJxWbeR4BFc6ldnpOnZFPTIDcajboBy0ij9a+nfBehLHAkpXk18+eC7RptetiqltrZ4r6v8MFjZJvQAgYPFPRyRz1G6dJ26mjHAqADHFWEh6Ece3pT057VKcAdOa2PNciLbwc9qo36jyj1yOlaDAkCqlzFvRg2CCKiSuioOzOG165mSIbDuYdc1w18XnfJHNegeIrVyxKEgdOvWsOPTtyMxX9K43e9me1QnFRucdMoC7cc4rg/iJqXzrZwgohG5wP0FepanZFWckYA6Yrw7xfdfatZuGX7inYv0FbUI3kTi6loadTn2NMNOamV2nktiZ4o70tHegkDSU6lxQA0Ckp+DTgtA7EVLipRH7UvlH0oCxBRUpTjpTStArDKUUYNFAEqHmvSfhJr0WnX9xa3blYbmPAOeAw6f4V5mtXbNyrqVOCO4oKjKzPt74cOJfCwdCcGR61YY8aRYL02mI9fcVyPwNunu/hzbSvy++RWJ6nBrswwFpYqOhKf070oq2hjVleTZbIxOvOflP8xVNh/ot+e5Zv/QRVzOJ1Jxjac8+4qsebW6ODnc9CMyd0U+V8o4b09jUPlIb5squPLHBUepqxIfmQ47/0NRJ/x/OdwwI1/maBakMMMX2JyYkJy5ztHqag1xY4rMNGgQ7wTtGKswbTZZGcYYg59c1T8Ttt09emPMGfapnomXT1kiC2clRg9RUGr2n2m1dScgjBpbE/ugTnFWnP7rJPbvWUoqUbM6E+WV0fJXxL0g6brkrIp27iDXC6lBuUToMr0bFe/fFyxSee4+UZPP44rxKHapkhk+6QRzU0ZaWO2tDmV+5zZop8q7JGX0NFdR570Oi8B2i3euxBlBCjdXp2rwbmKAfKgxXn3wvlSPxNGrjIdCv9a9V1WErEXZcbucn0rGtsehgzkmtRnFZt/bBVPeutt7bzDg8e57VS1Gy8x9oHJP51yXseny3Nz4N6Skt+ZZEH3h2r6JigEceFAWvPvhnoX9n2cDFRh1DdK9IPpW9HVNnj42a51FdCNF7MBT2OAMcmhjhgBn60yQ/Nx+YrU4txrSEggdarZkwd+32xVgKO/XuabIBjGfalYpGRqEKuvTr+lZ72oWIjI/AVsXA7EZqm5XBB/KsZpHVTk7HA+JRst5WRsOATyOOK+Z9SYtcSEkEliTX11q9il3Zzx4XcVIBx7V8k6tH5d5MnoxH608N1NcRLmijLam1MUP4VFius42IKXFKBzUsaZNAhqrmpY4S2MDmui8J+E9R8SXi2+nQM/wDfc8Kg9Sa+gfCfwn0XR7aN72MX16OWkbO0H2X/ABqJTsUkup4FoPgrVtYQvb25WEdZJPlH/wBetGbwJc299HEzb48je23A/Cvpt9Pii3fuxsCgKg7Hn/635VSm0SC4wzoBxnisXObeh0U/ZfaPO9G+HehXcKmWwAOOSJGGf1rbuPhZ4elg2Lp6xtjhkkfP6mu1s9OjgG1V7VrKgVeemKIp9WTUmr+6jw3Ufg/YyPttJ5YD05+YZriPE3ww1bSUeW2VbyBeSYgdwHutfURi6k/hWZqEQJbK89jTvKOok4y0sfGMtu0ZIZSCOxFQFcV9MeLvD1pqFlN5llA8u3hwoVs/UV494l8E3Om2S3turywf8tBjmP6+3vVxqp6BKg0uZHECrdoMuKgKYOMVs+GtNm1PVbW0t42kkkcDaPTvWpjY+ivCGoap4e8HWdnpRtzbzReaDLGWZSw5xggetXJfFuvrBZwqtntt2UsxjbLbRjB5qZlRYoYEXYkSCMKewAwKSW1XCkDPasJVmnodMaMGveWpctPGeuS3e97WxwF2hQGA65z1q4viDW3sp4fItTJIxYSDPygn0zUekWiHqpyBitpLWONcba0hO6uc9SFOLskRf8JLqLGPdZQAIcth254PtTB4jv1u55Xs4irKqqgkOQRnk8e9WjCpGB0x26VSu1jUEkAD1qnJERhFvYW38R3qaeIZLJDPgrvEh25/KrmoX6arZrDLbgHfk5ORXP8A2uFWA3CtSxljOCpHpWLqKWhq6KhqkaVpbRqmFXAA6Cm6oVSA7XYH2Y1YjkXYMYAHGKwvEF+I7aQngAHB6Cs6zSjYVKLnM8p8Y3IuJ7nEvTqCc5+lePavaNG7SJ2r1C8tnu7iaU5wzE4rB13S0W1bj5iOlZUnY9irBctjym65kyepoq3rlq1neNC4AZeuDRXfHVHiVFaTRN4ZmaDWbV16iQfzr6R8Q2DSabZyseHx8ytlSB7V81aEyRX8UshG1GBwe/NfT1jqEWpaAHiTam8MIweACvUUpxvB3NsPNxmjCtrOPYQSTzgY70xbAPfRDHJNbdnZEzc5BqUWojvo2PJHNedJaHsKpqek+FkVLCMdNo2itt8Y455rjLPVWtIWKgED1NQab4uuLzUBb+TGFB6hq1hWjCNmeTUw1ScnJbHbBiG5pjtzknpTAHKhuntUatlsuACPWt7nLYkBGflGe2aFZWDkU5cMDxxSGJcZHBHpTAoXAJbBAx2NY18TExd2wi9fSuhuIxt4PT9ayby2DZdske9YVItnRRkkUbFvNn+T5gV3cV8q+PIok8UaotuuIhcPtGO2TX1B5rWk6tGAF5Ax2riPif4Ctdb0241bTVMepRIXeNF+WbHX8etPDu2hpWj1PnB+Kixk1ektWViGBBzjBpotxkDmuu5z2K6R5r0H4a/D678W3JZma30+L/WT7c/go7mofh94JuvFOqJbwgpAvzSzYyEX/H2r6m0jS7TQtNt7K0URwxKEXjBJx1PuaiUtNBtWIfDmhWPh3R4bDT49kUa4LfxOfUnua0gCen601m9TQH6e/Xms9ydQZN3Xn2prwgdKd5iqw9eaY0gBzux9aYajdvzE9+mKC5DqpHB5zUM04HoKrNcgdMfWpbNFBs0WwRkHOeKhmhEg+cYGO9Z8V0DKAAc57VpROHxycelNO4nFxM2601GBJHNc1q+l+XGxiG4dCpGR+Vd1Ku4gEYxzWPqMYKsrA4zUzjpdGtKo76nzd4i8HStqm3S4JMvlmQ4Cr9D/AErd+E9hNpeqX0l3Zss0ShA7cFCeuPwr0O5QJMWVAXBzz6ZqFTufjjPYVCru1jpdCLlzI2LTM3znp71sRQgoQT6dao6ZBhB0IrZjTng4wetQlfcyqSs7IuadCEPHXHNaGMtjk8Z6VWtsbcDjtmrkYA4UcfWuqGiOGbbZTuoAPmXgjvn+dcV4u1B7S2lYEBQB/EATmu/uQ2w4H4Zrg/GGijUInJznHY1FVO2h0YVrm9483OvStJ97v69a6DSfFEkYCkg+5rmdU0F7cNjPy9/Suea5ns5CsgPHfPWuXl7HstQktT3GDxMkiqC2GrA1vVZL6ZrdWbyRjp3rzqy10xsN3P1PSul0m+jlQyMOT3Bo5W9zJU4U9Ua62iRxZfjjpXJeLnWOykY+laera0YSyZH515l408RNcE2cBBXHztnrW9ON2Y1anIrtnJajcNc3LyNk5PrRVVutFdaVjyW7u5NCcODX0p8Lp7O70CwVQY59pDszcHHpXzRGeRXv3w5mEfw6hl3QlkvGABHzj5R+lPoy6e6R6TFa+XKVZkYsM5FV5rc/avlHfqBUOmaik22RmyentV8ypM+5WwDnoK4qiT2PQi5RepVvZwtq4YdB1rB8NXottdRpfuHPNbGtxuIHyOMZ6Vx0NykUzGQnHUVzyWp10knBrue+RXqPApUgg0RLvy55zzXmul+JQlrHvJOAOa7DQfEdneRqscgyOq10Qqp/EeVVws6d2kdEFO3GMewp23coGcc5pI3WUZU8U7ITp0roOMjlj+XoKo3kIMffH61pg59PyqrcjHBzzSaRUW0zktRgCqT0AOay7bUyJCNuBnC89a6PVomkR8n5TxXL3Fs0LFl6dq5WuWV0elSkpRszjvFXw4g1u7lvNLkjtJH+YxMp2s3t6Vzlj8IdZkuMXU9pDGOrbix/AAV6rb3ewAmrf9pEjg5xya29roQ6TvoavgrQrXwzo6WdqAejSSH7zt3J/pW08ocnGMA1iwXTP5ZGcGtNclRjFOMuY5Zws9QZgWOPyqrcXAjyScYqS4YqOBk1l3Em8kZwaG7FwjcsfbU3ZJP1psl8pQn+tc1qWpR2bBMZ4rEute3KRETwD2rNzOuOHvqdTf6rGmQW5BqnHrsO/aTx3rzPXvEYtWAmZstyBWfY+IUuJQFYg1N5bm6pQWjZ7bYXsUrDy+Patm3YAnB4rzjwlcTTupXOCeprv4mIZVPJxziri7o5q9NRdjbGCpx+dZ2ooDG3Q1dhBK8nrUV8mYjjjitnqjijpI4O5fy5y0e0nJGSM4os7UNhuOlQ6ixjvyvQE/nWnp5B2gEYFca3PUk7RuatlFtjAP5VfjToRVeDKoO49qvW5XGc8HFaxOGbLEQIwe/86tRHJ6gAHn2qKMZJyKepUHGfmPUetaJ2OZ6k7AbMelY2qQsgyqeZlgMA+vFa45Bx+VKY93px2rTcUXynJX2jQzqodAGk4wcccGuA8UeDT5MmwgdwcdDXtJtFfazYJHPFVr7S0uImDAc8VnOndXR00sU4uzeh8jLCYrpo5TgoxBz2rfXWLfT7bazgELjNV/ixpdz4f8QSkx4inJeNgeD615rd3Us7EyOT7U4R5lc3qYjl0Rva94lN3I6wBgP7xNcw7FmJY5J6mkJptbKKWxxTqSnuFFFFMgcvBr1P4W6oq2dzZNLw4+6e3IP9K8r71ueE777Dq0bs2Fb5TTTKi7O57zpBMcjxFjtboa39IkeK9AkOVNcXpl/vVHznHI5roLTUFe4jIbAXmuKcbM9aMuaJ12oqkkDB+Dg45ryjXUa3nc44HSu7v9YjNuUU/jmuD1eX7Szlm/ClJXehVG8E7mYNZ8lSC9QWPimazvN8TlcHtWHqKlHOD3qhEpaYDkk01TT3HKs1sfUvww8RtrukFpCTJG+0nHX8a7puQD1/CvN/gvpj2/hxZWQr5rE/UDj/ABr0vG0YBOAK1p/CeTibKo7DAcDgVVusvjDYI5+tWiQuM559qztSuUhAJbntnvVSdkZQTb0Kd4MowUYI7461yuqTKodcnNdTId8ZP6HtWBqNosxwRnnP1rCaujsouz1MJcldy5/Co0ISRS3IHJGavmExkrg7f5Vm3ZQZPA47VDVkdsXdnQaVdNKBuACg/KMdBXSK2V29cjpXnukX4S4Vd3U131ofMiUjrj1rSk76HJiYcrKt/K0SZKnb34rIe6WSUgK7H/dNdTNGHXDAH3rDv7ON5kfJDR4ICnFVOLWpNKcdjgfGVnMVLoWOOeOteRap4nuoZGitSY9p5Zh83FfROpWguo9pGcZrwb4p6CdPv0uYoyI5RhsDo1TBLm1OmpUl7P3ehxd/f3F/cGa5kLue/pXReBtNn1DUVCq3lD7zY4FcvbRNLOqICWY4Ar6J8C6LDp2mQjywrqoLknkk1vPRWOajdy5mb/hnTzYwoCAFA4BHNdLArEhlAz7iqVuhY9Pl9quh2jICIWXHbrWS0LqSu7mlAzKp3Y6/pUWoy7YmGecUsLs+c5x+tU9WLG3YjH48CqlKyOaMbyOB1aRpLpzHgtk4BrY0WNzH8x546VgpHJcXzAA4BIrs9GtGSFO2PauWCuz0qz5Y2L0CMVx7Vet0K5LAkHnnpUcS4OM9BVoMAOBXQo9TzZybLUePp+FJPGjY3L0qkzyhsxevQ9DUyyM33lPSnzJ6Mz5WtRyuAQQ+D3GcirkeCCOnpisC8SSZwYZCkoOQf58Va0ya8WUR3cA29pUPH4g8iphOzsVKn7t7m2v1z+NOALDqDSJ83Jp3Uc5x9a6DmPD/ANpXTwdCsrsIvyzFC3fkf/Wr5llGGNfVX7SN5HF4SgtWGXlnDLz0xn/GvlSX75qafWxu23FXIz1pDS0n51oSJRRRTAWnKcHPQ02lFID0DwTrO9TbTN84Hy57iutW8KHcDXjVjcvaXUc0Z+ZDmu5tNVS8g3o3zY5FZ1I31O3DVbKzOxF8JRndzWbqTlY3dD71zQmk3kxyYx2z1qN9XYqY5OGNZKJ0ymQ3dxI7nvmtPwxZG61KBWHDMAfzqjaW0lzOpCnBPFdloQ+x6zZN5Y+V14XBJ5FNuyEld3PqDRrSO00+CCNQqogUD8KuOSO3Wm2mGt4yp4K08qM4PNaLY8eTu9SNz8n4VzV1aSTX/wBouCMJkIi9F9/c10zAAYrM1GLKHYdpHPHepnHmRrSnyvQzLq4WKPKnH1NZ9tIZtxYA88fSo7y2kkdFKsVByTmnKPLCjp2rG92daiktAmgDknbwRXMatbbGZfUE4rs4QGTINVNRs1kQHAyKpxuh06vLI8pEjwXYYjAB55r03w7qSS26g8sB0NcvfaSPNyFB5xwKksLee2UFTgjt61mk4s66vLVjY7+S5/dkoAT6VQaIvMZWHzlcEjpj0/Wsn7aYoxvJJxznqKjl1kmNljbDDp71q5J7nJGk1sbDrtyBj8a4X4m6el3oVyCMuozwPxroLS+ac5LH3zUPiRRcaXcorKP3bE/hUehtGPK7M+c/CUX/ABUNvnHytnn2r37w9c+bt3DluTx1rxLwZapP4rETnCjca9mdkthH5SgY4yO5q6krMVGPuWO3ssOqlOB7GrjLjHAFY+hXBaNC3pgVryy4HAFNuyOeSfNYtwgAA5BNZ+sKXidRnnirOmys7tvXaBwM9/ep5ljmyhAbPWs370TNPkmYOiaTsG5lHrXQRW4UY4zVuJVVMADpjipVQbeR+VaxhZEVKrm7spiBT2/KnSQgAE9asgAqxHGelJJyMH6U2jPmI41Up0FSLCDjg4FNto/LiCkliDwSfep1x68j0ppCbK7Wqtg49/ep4ogowDz0qXHJPFKMDGSM9RQopakuTEHBAGPrTmICkn68UmQBnPFZOtapFZWzu74C96bairsIxcnZHgf7SWprPqNnbI3+rUkj0rwaQ/Ma6r4g6s+qeIruZmyN5C854zXJtRSVo6m9Sydl0Gmig0laGYUUUUxC0ZpKWkMUVJDO8LBo2KkelRUtAXsXv7SnZwS3A9KviWKWVG80H61hA04HBpcppGq1uemaOoaINuxjtjOa3IZFhaJ92WDZrlvDt6JdLhBHzLwxPetqSUCNeeTXPNWZ6VKakj6h8H3632h2sisGIUAmttskcdPWvDfhX4o+ywi1mkOAx4PSvbLO6S5hV0YEN6VUJXVmeZiKThK62HY5681FKgI/xqyw4yKjYYz1rQwTMuS2G5jkkHoDVN7PcSdoHpxW2y8ZxmmmMDnHFKxoptGM9sQCqDDYz9eajliJXBGCe9bLJzyKiZA69BRYamznp7TAHfPqOKoTWrBfmAA6V080SgD1J4qq8CsuSMsKmUTaFU4bULVER2luGUk4CgdayU++MsRt/Wux1OBHDBo1yPUVyVzHtuWAGAPesHoz0aU+ZFiKTbg+9Pu54/IcyK0ilWGN2OSOOaqxplsE80lzE8kRVPm3cClc0aR4Yl3LpfiV5IXKlZSD7jNes6LqDXpRpDkivHvFi+V4hulAxh67nwjdkRRAk52itpK6TOei7SlE9k0eUEqASO2DW+mwgEniuK0K53FDnmulSQsMEkipb0M6kNTXt5kzgYq3FbwrK0qIFmcAMwHJA96xrBB9oySTxwexrej9CTiopu61OaquV6FiNfm79OKl6ce1IjcAE804k4J6YrpWxzMidgnJx0rMutWigfBYjH61g+MNfFrmKM9s/SuHXUZbqQuzsQfeuKpXbdono4fBc0eaZ6UniCJ3IVwa1rO9EwOMn3ry3T4WVt+SR2rpbbURbKMOOnQmlTqTT95jrYWK0idyJBg9aZNOoRsn2ye1ckmviQZWTAz61QvtfckhHDD1JrodddDlWFk2dRf6lHFEcsRx2rx74m+JvJ0518w7uRwcZrU1jXmEbuZPug8Zr5+8V65Nqt87M5MQJCj+tKKdR6nRyrDxv1MO5lMsruxyWJNVzSsaaTXWcLdwJpKXvRQAlFFFAhaKKKYwpaQdaOKAFpabRxQBcs76e1P7mQqPSun03X1njWO4wsnr2NcbmnK2DUuKZpCo4npFlezWcolgbH8jXrfgb4gvHCkU7KVBwQTyK+cbLWJoIvLOHQdN3atC21koweFijdwaydPsdKrRmrSPtfStdtr6IGORT7ZrV3qw4r430nx9fWOMNwO4NdlpPxlvIeJFjcDj5jSTmt0YyoQlrCR9KbgRnr2ppYZxXg8vxvAg4s4i/sxAqCz+NUjuRNZ5Vj1DdKrn8iFhpd0e+t0/nULpwa810H4o6feuEuCIXJ/iNd5aaza3SK0cqEN3BzQpxZMqM4dC3InQADmqU0ZMv+zjNaWQw+Uj2qOVPlORT3ITscxqyN5jEDnHNcbdkGYk9enSu01xXO9RgKRwQec1w12rK7HGfUgVjLRnqYbVEqBQfmzjHrTb8hINy845qW0UyxBwOSKgv9iBY5yVjz8zA81LR0X1PA/GzZ8RXZ6ZbNafgu+Z5REx5Xp9Kx/GMgk1+7KjC78DnPHak8JSbNXj9wa3teCOFTtWdu5734fHmBAf0NdlArFFA6n1rjvCCb/Lz3rvYSfkRV3P39vrWbSaNK0rMt2MABBwM9K1Is/h9aoQLg+taEIJYEnn8hTjGxxTdyYfNgkcVXvp/Jt2J6dhVgrjkDPPNcn431I2tvsXqePeprT5IhQp+0monB+J7oT6rKScqOlUbKXByo49Ko36NJIZtxVjyRUBv/scJOR61ywhc95+7GyOtGoC3iIO31HNYGpa3KCV3rsJ6GuM1XxNJJJsiGT35qglxPdODKWx7VuqZz8yTO+t9YOwANxVPUdeMcLu7lQO9c0bhbaAvI2xV9TXH6/r73wMMQ2xA9e5rSNK5jUrqKLXiHxTdXrvHC5SE8cdTXLMcnNIWzzTK6IxUdjzpzc3dgaSjNFMgKSiigANFLRQISiilpjCikpaQBR2o70UCFpelNpRTAcDTgcdKYKM8daBkwcjvSrIc1DmlFAXLAlOOtaek36xyBJh8pOM+lYmaejYNJoqMmnc9QsbKK5aNw2M4xiuz04XmktHJbTMY8jKivOvBeox3CCCZ2WWMZUgZyPzr1TTJVe3QNyK56kLnp0aiaPYvDzm5sI5WJJcVpshOOeKw/Cl5G9qkAxle1dE/PP6VdNWieXW0mzE1GzMpPPA46VhS6IGcnFdfIoJPpUfl844Jp8qZUK0orQ5CTSVtwwRdueeBXE+LyYVYbsDmvXrmEBeR+Brxf4t3SWNlLKoOcFPTk1lUjbRHbhqvM7yPn3VpzPfzSHnLE1b8LMq6xBuOMkgfWsmdtzknqTU+myiG9hc8hWBNb20scyn792fS3gJCWj5HXvXp9vCqLnGCT6V5Z8Mrj7RKm05UYOfavYoVGF+npWVLVGuMdpaEQgG4HP9asImDj+VPAB4yc0rHHNanBdsay4HY49s1wfj+2leIyI2Ap6GvQMADBzXJeMTG6rExOCenSufERvE6sJNxqXPJ7lCse/BYewrmPE0MklsrJlDjivQdQiG5U2kk85rl/EmwRFe5GMVnTVj1JS5keYxtHb3QW5bG7vWjcaza2cJKMJH6ACua8RzrJqDLG2VTjisktnrXWonmzrNNpGjqerT3zHeSqf3RWaTSUhNXY53JvcKTPFLSGgQUUUUAFJS0nagQUUUUAFL60najNAC0UmaKAF70UmaKBi9qXPFN70tAC+lFJ2ozQIdmim5oBoGOpQeabn2ozQBd067ezuY5oyQynNep+HfFdrcKse4pIP4W714+DU0M7ROGUkEHIIpNXNadVwZ9NaB4jNvLG8ZO9T8w9q9U0zxLY36KqS4cj7rcV8f6R4weBl+0gk4wWWukg8e2qciSQHvxWXLKOx0z9lW3dj6qN7ASWDrjuc1KJ48ZDDFfMkHxJtBDsF1cQk9So4NSWnxUNrE0YumlVuu5SaFOfYyeHh0me+a/wCIbLTbVpJpR34Wvl/4qeMv7dvTBanFqpzjHU1Y1/xxbX9pMZJ2kmIIVdpwM15jNNvYmqUW3eQpONNcsHcRm60sbYYGos0BuetaGFz2n4N+LYLO6S0vGOTwrY7V9D6TrFreJ+5lDY49K+HNOvns7qOaM4ZGyK9a8KfEm1sNhmcjP3hg1jNSi7xOmPJVjaTs0fTrToBwagbUIUfDSAduteI3vxX0uSL91dyK3oUNcff/ABKeW4IiuCq5+9is3Um9kEMNC3vSR9LXms21vEXeUBa4bWtbiklaVyQueM15Lb+OrV13XN2S2eFAIqSbxlpMjgyXYJH+ycVMlOT1R0U6dKnrzHZ32ox3Ue8ZAxgdj9a4HxZqggtZJJD8/wB0Duah1bxnp7BhDLuGOAoNee65qz6lcl2JCD7q+lawhrqTVrxirRKEz73Zj1JzUdJmkrc89i0UmaM0AFFFFABR3pDRQAp60lHWigAopKKAFpT1oooATtQaKKADsDRRRQAUtFFACdqUdKKKBAaO1FFAwNA70UUCQCngCiigZMiKWAI4q7HBGSPl/WiihlEv2aLB+T9TSG2i2D5P1ooqRleaGMA4X9aoSAA0UVXQljDQOtFFAhwHNWYkXA4oooQIumCPC/L29agkiQKSBz9aKKnqaEZRQp47UxlABxRRQIiYdKjNFFUS9w9KSiikIWkoopiDsKT1oooGFBoooEIaKKKBijtRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal brain section in holoprosencephaly demonstrating single ventricle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_16_21775=[""].join("\n");
var outline_f21_16_21775=null;
